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vSUMMARY
Malaria continues to be of major public health importance, especially in sub-Saharan
Africa. At a minimum, 900 million acute febrile episodes occur yearly resulting in 1-3
million deaths yearly, mostly in African children below 5 years of age. Less than 20% of
these deaths come to the attention of any formal health system. The World Bank (1993)
ranks malaria as the leading cause of lost disability-adjusted life years (DALYs) in Africa
with an estimated 35 million future life-years lost from disability and premature death.
Without effective malaria control programme(s), the massive burden of malaria
morbidity and mortality is expected to at least double in the next 20 years due mainly to
the growing spread of Plasmodium falciparum resistance to Chloroquine and other anti-
malarials. Lack of development of new affordable drugs; the financial constraints on
health services in most countries; and lack of expertise to plan properly for malaria
control are also sources of worry. Hope has been re-kindled by the initiation of the Roll
Back Malaria (RBM) whose goal is to reduce malaria by half in 10 years. 
The goal of the present study is to characterise the epidemiology of Plasmodium
falciparum parasites, patterns of seasonality in infection and morbidity and their
relationship to radical cure in the Kassena-Nankana district (KND) in northern Ghana.
Such information prior to clinical malaria intervention trials will be important for optimal
design and implementation. In the KND, malaria transmission is holoendemic with
seasonal peaks and troughs mirroring the wet and dry seasons in the district. It is the
leading cause of both morbidity and mortality, accounting for 60% of hospital
admissions, and 35% of all deaths 
Cohorts of either non-immune children or semi-immune adults or all age groups were
randomly selected using a cluster sampling approach that was facilitated by the availability
of the Navrongo Demographic Surveillance System (NDSS). In total, between 200 and
300 inhabitants constituted the cohort for each of the studies. With all eligible people
within the district included in the sample frame, and using the Stata program, 16 "index"
compounds were randomly selected. Potential volunteers were recruited sequentially
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from nearby compounds in order of proximity to the "index" compounds until the
required number of volunteers was made up. Participants screened based on criteria pre-
determined were enrolled to participate in the study. Those studied for incidence of
infection and first clinical malaria were treated with anti-malarials to clear them of all
malaria parasitaemia prior to follow-up. They were then followed prospectively for at least
four months to determine re-infection, and clinical malaria. The selection procedure in
those studies for parasite genotypes and severe anaemia were the same, but these
studies were carried out as cross-sectional surveys.
The main findings were:
Malaria transmission was found to be intense throughout the year, with seasonal peaks
and troughs. The overall prevalence of P. falciparum was 70% by microscopy and 82%
by PCR with the highest parasite rates among 5-9 year olds and highest parasite
density (geometric mean 1,922/µl blood) in 1-2 year olds. PCR-RFLP typing of the P.
falciparum msp2 gene revealed a mean multiplicity of 3.4 (range: 1 to 8) genotypes with
the two msp2 allelic families (FC27 and 3D7) in almost equal proportions. The
correlation between parasite density and msp2 multiplicity was highest in infants, and
decreased with age to a minimum by 10 years, then start to increase again from this
age into adolescence and adulthood.
The incidence density of P. falciparum infection in both infants/young children and
adults was the same (ID = 7.0 cases/person-year) in the wet season, and only
decreased slightly (5.0 cases/person-year) in the dry season. The cumulative incidence
of infection profiles in both age groups indicated the same rapid rise with over 90% re-
infection rate within 12 weeks post-treatment.
The risk of developing febrile parasitaemia of >5,000/l, >10,000/l, >20,000/l and
>50,000/l during the wet season was 1.92, 1.93, 2.45 and 4.33 times that of the dry
season with p-values always less than 0.0025.
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Malaria parasites were cleared prior to following up on the cohorts in order to determine
incidence of P. falciparum infections. This resulted in 49% of volunteers in the treatment
group experiencing clinical attacks of malaria compared to 38% in the untreated group
[RR (95% CI)=1.29 (1.03-1.61)]. Clinical malaria in the treated group was associated
with significantly more symptoms and lower parasitemia.
Severe anaemia defined as Hb<6.0g/dL, at the end of the wet season (November 1996)
was 22.1% compared to 1.4% at the end of the dry season (April 1997), [OR (95%
CI)=20.1 (7.1 – 55.3)]. Nutritional and hookworm anaemia appeared to have little impact
upon this seasonal difference since anthropometric indices were comparable with no
hookworm infection among 6-24 months aged children. A repeat survey in November
2000 confirmed that the proportion of severely anaemic children and overall mean
haemoglobin levels, in the 2000 sample were significantly improved over those of the
1996 (17.5 % vs. 26.4%, P = 0.03; Hb 7.5 g/dL vs. 6.9 g/dL, P = 0.002). Relative to
children with Hb6.0 g/dL, those with severe anaemia (Hb<6.0 g/dL) were older, more
frequently parasitaemic [OR (95% CI)=1.60 (1.08-2.35)], more often febrile [OR (95%
CI)= 2.44 (1.71-3.48)], and predominantly male [OR (95% CI)=1.50 (1.05-2.13)].
These findings bear upon the design of malaria drug and vaccine trials in holoendemic
areas such as the KND. Optimal design of malaria intervention trials, ie sample sizes
calculations and follow-up could be borne out of these findings. Changes in the
multiplicity of infections based on msp2 genotyping can be used for assessing the
outcome of malaria clinical intervention trials. The evidence also suggests that dramatic
peaks and troughs of severe anaemia are regular and possibly predictable events that
may be used to assess malaria clinical intervention trials in areas similar to the KND.
Evaluation of some clinical malaria intervention trials will require clearance of
parasitaemia prior to follow-up. The interpretation of such intervention trials need to be
carried out with a lot of caution as clinical malaria occurring after clearance of malaria
parasitaemia may be distinctly different from "natural" disease and this may have
significance for the design and interpretation of intervention trials.
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ZUSAMMENFASSUNG
Die Malaria gehört nach wie vor zu einem der wichtigsten Gesundheitsprobleme,
insbesondere in Afrika südlich der Sahara. Jährlich werden mindestens 900 Millionen
akute Fieberepisoden und 1-3 Millionen Todesfälle verzeichnet, grösstenteils in
Afrikanischen Kindern unter 5 Jahren. Weniger als 20% dieser Todesfälle werden von
den formalen Gesundheitssystemen erfasst. Die Weltbank (1993) stuft die Malaria als
die wichtigste Ursache für verlorene "Disability-Adjusted Life Years" (DALYs) in Afrika
ein und schätzt die Anzahl der durch Behinderung und frühzeitigen Tod verlorener
Lebensjahre auf 35 Millionen.
Es wird erwartet, dass sich die massive Last der Malaria Morbidität und Mortalität ohne
effiziente Malaria-Kontrollprogramme in den nächsten 20 Jahren verdoppeln wird. Diese
starke Zunahme ist vor allem auf die sich ausbreitende Resistenz von Plasmodium
falciparum gegen Chloroquin und andere Malariamedikamente zurückzuführen.
Beunruhigend ist auch, dass sich keine neuen preisgünstigen Medikamente in der
Entwicklung befinden, dass in den meisten betroffenen Ländern die finanziellen
Resourcen der Gesundheitssysteme stark begrenzt sind, und dass  die Expertise zur
Planung von effizienten Kontrollprogrammen oft unzureichend ist. Eine gewisse
Hoffnung wurde durch die Initiative "Roll Back Malaria" (RBM) geweckt, die sich zum
Ziel gesetzt hat, Malaria innerhalb der nächsten 10 Jahren um die Hälfte zu reduzieren.
Das Ziel der vorgelegten Studie ist es, die Epidemiologie der Plasmodium falciparum
Parasiten zu charakterisieren, die Saisonalität von Infektion und Morbidität und deren
Verhältnis zu Radikalbehandlungen im Kassene-Nankana Distrikt (KND) in Nord-Ghana
zu untersuchen. Solche Informationen werden für die Planung und Durchführung
künftiger klinischer Malaria Interventionsstudien von Bedeutung sein. Im KND ist die
Malariatransmission holoendemisch und spiegelt durch saisonale Höhen und Tiefen die
Regen- und Trockenzeiten im Distrikt wider. Malaria ist die wichtigste Ursache für
Morbidität und Mortalität, verantwortlich für 60% der Spitalbesuche und 35% aller
Todesfälle.
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Kohorten von entweder nicht-immunen oder semi-immunen Erwachsenen oder von
allen Altersklassen wurden randomisiert ausgewählt. Es wurde ein "cluster sampling"
Ansatz verwendet, der durch das "Navrongo Demographic Surveillance System"
(NDSS) ermöglicht wurde. Für jede Studie wurde eine Kohorte von 200 bis 300
Einwohnern rekrutiert. Alle in Frage kommenden Einwohner des Distriktes wurden in
einer Stichprobengesamtheit zusammengefasst und 16 "Index"-Haushalte mit Hilfe des
STATA Programmes randomisiert ausgewählt. Potentielle Freiwillige wurden aus den
Nachbarhaushalte rekrutiert bis die gewünschte Anzahl Freiwillige erreicht war. Die
ausgewählten Personen wurden nach Überprüfung hinsichtlich vorbestimmter Kriterien
in die Studie aufgenommen. Die Personen, die an der Studie über Infektions-Inzidenz
und erste klinische Malariaepisoden teilnahmen, wurden mit Malariamedikamenten
behandelt, um sie vor den Nachfolgeuntersuchungen von allen Malariaparasiten zu
befreien (Clearance). Sie wurden danach während mindestens 4 Monaten überwacht,
um Neuinfektion und klinische Malaria zu erfassen. Das Auswahlverfahren in den
Studien über Parasitengenotypen und schwere Anämie war dasselbe, ausser dass
hierbei Querschnitts-Analysen durchgeführt wurden.
Die wichtigsten Resultate waren:
Mit saisonalen Höhen und Tiefen wurde eine hohe Malariatransmission während des
ganzen Jahres beobachtet,. Die P. falciparum Prävalenz war 70% bei mikroskopischer
Bestimmung und 82% bei PCR-Bestimmung. Die Prävalenz war bei 5-9 jährigen
Kindern am höchsten und die höchsten Parasitendichten wurden bei 1-2 jährigen
Kindern gefunden (geometrische Mittel 1.922/l Blut). PCR-RFLP Typisierung des P.
falciparum msp2 Gens zeigte, dass Personen im Schnitt mit 3.4 (Umfang: 1 bis 8)
verschiedenen Genotypen infiziert waren (Mulitplizität der Infektion). Die beiden msp2
Allel-Familien FC27 und 3D7 waren zu beinahe gleichen Anteilen vertreten. Die
Korrelation zwischen Parasitendichte und msp2 Multiplizität war am höchsten bei
Kindern, nahm mit dem Alter ab, erreichte ein Minimum bei den 10 jährigen und stieg
dann mit dem Alter wieder an.
xDie Inzidenz der P. falciparum Infektion war bei Kindern und Erwachsenen gleich, lag
bei 7.0 Fällen pro Personen-Jahr in der Regenzeit und war in der Trockenzeit (5.0 Fälle
pro Personen-Jahr) nur geringfügig reduziert. Auch die kumulative Inzidenz war in
beiden Gruppen gleich und zeigte einen raschen Anstieg der Reinfektionsrate bis auf
über 90% während den ersten 12 Wochen nach Behandlung.
Das Risiko, eine febrile Parasitämie mit >5‘000/l, >10‘000/l, >20‘000/l und
>50‘000/l zu entwickeln, war in der Regenzeit jeweils 1.92, 1.93, 2.45 und 4.33 mal
höher als in der Trockenzeit (alle p-Werte <0.0025).
Um die Inzidenz der P. falciparum Infektion zu bestimmen, wurden die Kohorten vor den
Nachuntersuchungen von Malariaparasiten befreit. Dies führte dazu, dass 49% der
Freiwilligen in der behandelten Gruppe klinische Malaria entwickelten im Vergleich zu
38% in der unbehandelten Gruppe [RR (95% CI)=1.29 (1.03-1.61)]. Klinische Malaria
war in der behandelten Gruppe signifikant mit mehr Symptomen und geringerer
Parasitendichten assoziiert.
Schwere Anämie, definiert als Hb<6.0g/dL, war am Ende der Regenzeit (November
1996) mit 22.1% weit häufiger [OR (95%)=20.1 (7.1-55.3)], als am Ende der Trockenzeit
(1.4% im April 1997). Ernährungs- und Hakenwurminfektions-bedingte Anämien
schienen bei diesem saisonalen Unterschied keine Rolle zu spielen, da die
anthropometrischen Parameter in Hakenwurminfizierten-und nicht-infizierten 6-24
Monate alten Kindern vergleichbar waren. Eine Nachfolgestudie, die im November 2000
durchgeführt wurde, hat gezeigt, dass in der 2000er Kohorte der Anteil der schwer
anämischen Kinder im Vergleich zu der 1996er Kohorte abgenommen und die
Hämoglobinwerte signifikant zugenommen hatten (17.5% vs. 26.4%, p = 0.03; Hb
7.5g/dL vs. 6.9g/dL, p = 0.002). Im Vergleich zu Kindern mit Hb6.0g/dL waren die
schwer anämischen Kinder (Hd<6.0g/dL) älter, hatten öfter eine Parasitämie [OR (95%
CI)=1.60 (1.08-2.35)], hatten öfter Fieber [OR (95% CI)=2.44 (1.71-3.48)] und waren
häufiger männlich [OR (95%)=1.50 (1.05-2.13)].
xi
Diese Resultate haben wichtige Implikationen für die Planung von klinischen Studien
zur Erprobung von Malariamedikamenten und -Impfstoffen in holoendemischen
Gebieten wie dem KND. Solche Malaria Interventionsstudien sollten hinsichtlich der
Teilnehmerzahl und der Festlegung von Nachfolgeuntersuchungen basierend auf
diesen Ergebnissen entworfen werden. Durch msp2 Genotypisierung nachgewiesene
Änderungen in der Multiplizität der Infektionen können dazu verwendet werden, die
Endpunkte von Malaria Interventionsstudien abzuschätzen. Die Resultate zeigen, dass
die dramatischen Schwankungen in der Häufigkeit schwerer Anämien regelmässige und
möglicherweise voraussagbare Ereignisse sind, die in der Auswertung von Malaria
Interventionsstudien in Gebieten wie dem KND einbezogen werden müssen. Die
Evaluierung gewisser Malaria Interventionsstudien wird die Eliminierung von
Parasitämien vor den Nachfolgeuntersuchungen voraussetzten. Solche
Interventionsstudien müssen mit grösster Sorgfalt interpretiert werden, da sich klinische
Malaria, die nach dem Eliminieren der Parasitämie auftritt, sehr von der "natürlichen"
Malaria unterscheiden kann. Dies kann für die Planung und Interpretation von
Interventionsstudien von grosser Bedeutung sein.
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Chapter 1
___________________________________________________________________
INTRODUCTION
21.1 The burden of malaria
Malaria continues to be the most important parasitic disease of humans. It is of major
public health importance in the tropics, especially in Africa south of the Sahara, where it
remains a leading cause of morbidity and mortality. The current statistics leave close to
half of the world’s population at risk of being infected with this dreaded parasite (World
Health Organisation, 1996a). Between 400 and 900 million acute febrile episodes occur
yearly in African children under 5 years of age living in endemic areas (Breman, 2001).
At a minimum, 0.7-2.7 million deaths occur yearly from malaria, about one million in
children below 5 years (Breman, 2001), (World Health Organisation, 1996b). Over 75%
of these deaths occur in sub-Saharan Africa (World Health Organisation, 1997a). In
Africa, 25-30% of all deaths among children under 5 years of age are attributed to
malaria (Molineaux, 1985); (Greenwood et al.  1987); (Payne et al.  1976); (Snow et al.
1999), but less than 20% of these deaths come to the attention of any formal health
system. 
Severe anaemia due to malaria is now believed to occur in between 1.5 to 6.0 million
African children per year with case fatality rate of nearly 15% (Murphy et al.  2001).
Respiratory distress, hypoglycaemia and overlapping conditions contribute another 1-2
million cases with mortality nearing 20% (Murphy et al.  2001). Malaria-related effects
on pregnant women, their foetuses, and new-borns comprise an extremely large and
often hidden burden (Steketee et al.  2001); (Murphy et al.  2001). Over 400,000 women
develop severe anaemia during pregnancy annually as a result of malaria in sub-
Saharan Africa.  
The World Bank ranks malaria as the leading cause of lost disability-adjusted life years
(DALYs) in Africa with an estimated 35 million future life-years lost from disability and
premature death (World Bank, 1993). Malaria reduces the capacity for children to learn
and the productivity of the work force and drains national treasuries. According to new
research by Harvard, London School and the World Health Organisation, Africa's GDP
would be up to $ 100 billion greater than it is currently if malaria had been eliminated
years ago (World Health Organisation, 2000a). It has been documented that in areas
3where malaria was eliminated, economic growth increased substantially over the
following five years compared to growth in neighbouring countries (Gallup et al.  2001). 
Without effective malaria control programme(s), the massive burden of malaria
morbidity and mortality is expected to at least double in the next 20 years. One reason
is the growing spread of Plasmodium falciparum resistance to Chloroquine and other
anti-malarials. From data collected in Senegal, Trape (2001) demonstrated a two- to
three-fold increase in hospital admissions and deaths, and a six-fold increase in child
malaria mortality when Chloroquine resistance emerged in the late 1980s and early
1990s. Other reasons include lack of development of new affordable drugs; the financial
constraints on health services in most countries; lack of expertise to plan properly for
malaria control, and the wars in Africa  that have and continue to disrupt health services
in those countries. 
Hope has been re-kindled by the recent initiation of the Roll Back Malaria (RBM) whose
goal is to reduce malaria by half in 10 years (Nabarro et al.  1998); (Alnwick, 2000).
Implementation of malaria control interventions is therefore expected to increase. The
correct and timely application of current malaria control strategies (personal protection,
drug use and vector control), can result in significant decrease in malaria-specific and
overall mortality. Though it will take a while before a vaccine of public health importance
is made available and affordable to people living in rural sub-Saharan Africa, the
momentum for discovery of new and effective anti-malarial drugs as well as vaccines
should be intensified. Funding of research towards the discovery of new anti-malarial
drugs and vaccines should be made available in institutions with capabilities and in
different epidemiological settings for testing of these drugs/vaccines. It is important to
ensure that potential sites where such new vaccines and drugs are to be tested are well
characterised, in terms of their malariometric indices, prior to testing. 
41.2. Determinants of the malaria burden 
To propagate malaria transmission, intrinsic factors related to humans, mosquitoes and
human malaria parasites are required in the presence of suitable environmental
conditions. Other contributing factors include social, economic and behavioural. The
most important extrinsic factors include rainfall, economic conditions, social,
behavioural, and political commitment as well as effectiveness of control and preventive
efforts.
Parasite: Human malaria disease is caused by infections from 4 plasmodia species,
Plasmodium falciparum, P. vivax, P. malariae and P. ovale. Of these, P. falciparum is
the most virulent and the most widespread in Africa (Gilles, 1985). P. vivax is not
common in Africa, especially West Africa because Duffy antigen, the receptor on the
surface of red blood cell to which merozoites bind is rare in African populations.
Transmission of Plasmodium parasites is from person to person through the bite of a
female anopheles mosquito (Fig. 1.1:). 
Figure 1.1. The life cycle of Plasmodium species. (By courtesy of Stephen Hoffman)
5The life cycles of all human plasmodia species transmitted are the same with three
reproductive phases. The species differ in the time taken to complete each phase. An
initial stage consists of a single cycle of sexual reproduction that occurs in the female
mosquito (sporogony), leading to production of sporozoites. At ambient temperature of
24oC, sporogony takes 9 and 21 days in P. falciparum and P. malariae respectively.
When the infected mosquito bites man, it injects the mosquito into the blood. The
sporozoites then travel to the liver cells and develop the second phase, a single cycle
asexual reproduction takes place within five to seven days. This "hepatic schizogony" or
"pre-erythrocytic" phase results into merozoites that enter the blood stream, after
bursting of the liver cells. The third and final stage "erythrocytic schizogony" phase
takes place in the red blood cells and consists of several cycles (each lasting 48 hours
in the case of P. falciparum), of asexual reproduction. New merozoites are produced in
each cycle and these re-invade new red blood cells, starting the erythrocytic cycle
again. Some of these merozoites, however, differentiate into male and female
gametocytes that are taken up by the blood-sucking Anopheles to start the next
sporogonic cycle. Each stage of these cycles is a target under investigation for potential
malaria vaccines (Hoffman, 1996). 
Vector: Anopheles gambiae ss and Anopheles funestus are the most efficient vectors
for Plasmodium falciparum malaria transmission (Service, 1996). Their human biting
habits and longevity makes them efficient vectors of malaria. The entomological
inoculation rate  (EIR), the number of sporozoite positive mosquito bites per year is the
most common measure of malaria transmission. A high EIR results in stable and
intense transmission, leaving young children as the vulnerable group, while a low EIR
results in a wider age range of individuals being susceptible and developing severe
infections and illness. 
Host factors: Availability of human populations susceptible to malaria infections is a key
factor. The genetic make up of humans can limit parasite multiplication and thus protect
them from malaria. Sickle cell trait, Duffy blood factor, hereditary ovalocytosis,   
6Glucose-6-phosphate dehydrogenase deficiency, and thalassemia among others have
been associated with decreased susceptibility to severe malaria (Luzzatto, 1979). 
The immune status of the individual and of populations plays the most important role in
the clinical response to infection and transmission. Maternal antibodies in new-borns
are augmented by exposure later in life in highly endemic areas. Immunity is never
complete, irrespective of the level of exposure, so malaria premunition (parasites and
antibodies without symptoms) comes into play. Identification of specific immunologic
determinants of protection will lead to development of the most promising vaccine
candidates.
Extrinsic factors: These include environment, social, behavioural, political and economic
factors. Climatic conditions in most tropical areas: warm temperature, heavy rainfall,
high humidity is conducive to mosquito breeding and longevity and parasite sporogony.
Engineering projects such as construction of dams for hydropower and irrigation, roads,
industrial and residential centres usually result in water collections leading to increased
mosquito breeding. Epidemics linked to rainfall, temperature, geography, and population
susceptibility have been reported (Lepers et al.  1991); (Connor et al.  1999).
Improvements in education, economic and social conditions impact on malaria
transmission (Koram et al.  1995). Filling in of swamps, elimination of open drainage
ditches and other breeding sites, screening of windows and doors, widespread use of
air conditioning and availability of rapid diagnosis and drugs for acute illnesses are
related socio-economic status. The recent heads of states malaria conference in Abuja
gave political support that raised the hope of commitment for malaria control (World
Health Organisation, 2000b).
71.3. Manifestations of malaria
Malaria infections can result in asymptomatic parasitaemia, clinical malaria (febrile
episodes, parasitaemia); severe malaria (anaemia, neurologic syndromes) and mortality
(Breman et al.  2001). 
The local epidemiologic profile of malaria in the context of other diseases is very
important for diagnosing and quantifying accurately the cause of febrile illness
(Rougemont et al.  1991). In its mild form, malaria presents as a febrile illness
associated with other non-specific signs and symptoms. The fever may be periodic and
interspersed with afebrile intervals. Malaria may be confirmed by the presence of the
parasite in the peripheral blood. Parasitological diagnosis does not necessarily mean
that malaria is the cause of the disease. 
Acute severe illness can lead to cerebral malaria, with a high case fatality (World Health
Organisation, 2000c); (Molyneux et al.  1989); with coma, severe anaemia, respiratory
distress and hypoglycaemia being ominous. The debilitating acute and chronic effects of
anaemia and neurologic, cognitive and developmental impairment are not well
quantified (Slutsker et al.  1996); (Newton et al.  1998); (Brewster et al.  1990); (Van
Hensbroek et al.  1997); (Verity et al.  1998). The effects of malaria on pregnant women
and their foetus include severe malaria attacks on expectant mothers leading
sometimes to death; low birth weight and subsequent increased infant and childhood
mortality (Bloland et al.  1996); (Slutsker et al.  1996).
1.4 Rationale for the studies
The current malaria control and prevention measures include personal protection, drug
use and vector control strategies. The appropriate and timely use of these strategies
could result in significant decreases in malaria specific and overall mortality. It is,
however, difficult to achieve and sustain this. Though the role of drug treatment is
paramount among the control methods, the emergence/resurgence of resistance to anti-
malarial drugs is still on the ascendancy. Chloroquine, which still remains the first-line
drug in most African countries cures only a proportion of malaria infections. Studies
8carried out with Sulphadoxine-Pyrimethamine (SP), the second line drug in these
countries and currently the first line drug in a few other countries in Africa indicates that
the malaria parasites are developing resistance against this drug at a faster rate than to
Chloroquine. The few new anti-malarial drugs that have so far been discovered are
beyond the pockets of the ordinary African family. It is therefore imperative that new
anti-malarial drugs that will be cheap, affordable and effective (similar to Chloroquine)
are discovered before the current ones become obsolete. This means that testing of
new, potential anti-malarials in endemic areas will have to increase over the coming
years.
The search for an effective vaccine against the disease will be another major
strengthening of the malaria control process. Availability of the local epidemiologic
profile of malaria prior to testing new drugs or vaccines will contribute to optimal design
and evaluation of the study and generate reliable results that can be interpreted with
confidence. Determination of malaria parasite genotypes and dynamics of the infection,
attack rates, antigen variability, morbidity trends are essential for planning efficacious
and effective vaccine and drug trials.
With the Kassena-Nankana district of northern Ghana earmarked as one of the potential
sites for clinical studies including testing of new anti-malarial drugs and vaccines, an
important first step is to characterise the malaria epidemiology in the area.
Measurement of the incidence density (ID), which estimates the force of infection
exerted by a pathogen upon a defined population, a true attack rate and the cumulative
incidence (CI), which also estimates the risk or probability of infection during a defined
period, are crucial for determination of sample sizes for trials. The ID and CI provide a
good foundation for forecasting the frequency of new infections and disease and thus
permit the application of optimal methods for formulation of strategies for interventions
or the design and evaluation of drug or vaccine trials (Jones et al.  1994); (Beier et al.
1994). 
9Intervention trials of malaria vaccines or drugs may require radical cure of volunteers
prior to follow-up for end points of interest. There has been no direct evaluation of the
possible impact of radical cure on incidence and severity of subsequent symptomatic
malaria.  Does the elimination of parasitaemia render the host more susceptible to
disease by parasitaemia introduced by re-infection? Does the drug(s) used for parasite
clearance affect the immune system or interrupt premunition? Though the study of
Pringle & Avery-Jones (1966) on the early course of untreated falciparum malaria in
semi-immune African children following a short period of protection indicated that many
of the new infections caused clinical symptoms of malaria and a parasitaemia that was
significantly greater than had prevailed generally before treatment, there has not been
any follow-up studies all these years to substantiate on this finding. This study
concluded that even short period of a few weeks of drug protection against malarial
infection had lowered the immunity of the children to an appreciable degree. 
There has been a long-standing discussion on rebound effects following successful
interventions (Snow et al.  1997), and the use of chemoprophylaxis or drug treatments
(Menendez et al.  1997); (van den et al.  1996); (Greenwood et al.  1995). These studies
reported significantly higher incidence of clinical attacks of malaria and severe anaemia
after the interventions (medication/ bed net use) was stopped among children who had
previously received antimalarials than among children who had previously received
placebo; an impairment of the development of natural immunity.  The question about the
effects of completely clearing malaria parasites prior to assessing malaria interventions
still remain relevant, especially to intervention trials where subtle differences in
susceptibility affect end points of effective or ineffective outcomes.
A major strengthening of malaria control can be achieved through the availability of an
effective vaccine against the disease. Though it has long been suggested that malaria
vaccines should aim to mimic the effects of naturally acquired immunity (Alonso et al.
1996), we still do not understand some of the fundamental issues on the effects of long
term exposure to malaria parasites on immunity. Does acquired immunity against pre-
erythrocytic antigens results in a reduction in the incidence of new blood stage
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infections, as the host grows older? It is still unclear how acquired immunity to blood
stages affects the persistence of individual infections. We know however, that genetic
diversity of parasites is frequent within species, patients and localities, due to
recombination and selection. Such evolved parasites may alter clinical presentations
and impact on the number of cases resulting in various age groups due, probably to the
presence of more virulent forms (Jiang et al.  2000); (Gupta et al.  1994). 
Studies of Plasmodium falciparum infections that people are exposed to gain a better
understanding of the factors that impact on the development of immunity in different
endemic areas will improve our knowledge of the use of molecular tools in the choice of
new anti-malarial drugs and vaccine formulations. The design and evaluation of
effective control measures against the parasite could improve with indepth knowledge of
the molecular epidemiology in endemic settings. For example, the trial involving the
SPf66 vaccine did not protect young Gambian children against clinical attacks of
malaria.  The knowledge about the genotypes in this area prior to testing the vaccine
resulted in significantly fewer detectable P. falciparum genotypes than in control
children (Haywood et al.  1999).  Furthermore, knowledge of genes associated with
disease or resistant to a drug or a vaccine in an area and the frequency of such genes
are relevant as this could affect the outcome of interventions. Genetic diversity may
account for the protective immunity and the frequent repeat infections and clinical
episodes of malaria in persons, particularly young children, living in areas of intense and
stable transmission, and this must be considered in the development of vaccines.
Multiplicity of falciparum infections has been documented to reach high levels of up to 9
different parasite clones at a given time in a single asymptomatic host.  This has been
shown to be positively associated with protection against mild episodes of malaria in
some circumstances (Smith et al.  1999a); (Al Yaman et al.  1997); (Beck et al.  1997);
(Contamin et al.  1996); (Ntoumi et al.  1995). This further suggest that concurrent
infections provide protection from super-infecting parasites and that concomitant
immunity is, at least in part, a consequence of a response to the major merozoite
surface proteins. The number, or multiplicity, of infection in a host may confer the
degree of immunity against P. falciparum, and the risk of clinical malaria.
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PCR-RFLP genotyping of parasites for msp2 makes it possible to distinguish the
individual parasite infections concurrently present in a blood sample (Felger et al.
1999). The possibility of tracing individual parasite clones over time allows detailed
studies of infection dynamics. In immunological studies, genotyping can also provide
important information on the diversity of antigenic challenge. Most importantly,
genotyping makes it possible to determine the multiplicity of infection, which can be
used as an outcome measurement of interventions such as drug trials, vaccine trials, or
exposure-reducing interventions. The msp2 of P. falciparum is not only an extremely
polymorphic marker gene, but considered a prime candidate for inclusion in a sub-unit
malaria vaccine against blood stage malaria (Engelbrecht et al.  1995). Msp2, as part of
a sub-unit vaccine, entered into field trial in PNG (Genton et al., 1996); (Genton et al.,
2001). Not only is msp2 frequently and strongly recognised by the immune system of
individuals exposed to malaria (Al Yaman et al.  1994); (Rzepczyk et al.  1990), but
monoclonal antibodies against msp2 prevent invasion of erythrocytes by merozoites in
vitro. Two genotyping studies from PNG have already shown that the 2 allelic families of
msp2 are differently associated with morbidity. Parasites carrying the FC27-like
genotype were twice as likely to be found in symptomatic malaria infections. 
Infection, morbidity and/or mortality due to an infection are common end points of drug
and vaccine trials. Malaria drug or vaccine trials with incidence of infection/re-infection
as end point are not difficult to determine. This is however, not the case with drug or
vaccine trials that have malaria morbidity and/or mortality as end point. In most endemic
sites, malaria is normally one out of several common infectious diseases that occur. The
presence of malaria parasitaemia with or without fever is not conclusive that the
morbidity is due to malaria. It is therefore difficult to have a clear-cut definition for
malaria morbidity in malarious areas. The disadvantages of malaria mortality are not
only due to the difficulty in defining exclusively the attribution of malaria, but more
importantly this is a rarer event that will require a very large population or long period of
follow-up. 
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Severe anaemia, one of the manifestations of severe malaria, seems easier to assess
as an end point of malaria vaccines when considering the control effects of malaria in
endemic sites where severe anaemia is a regular annual phenomenon.  In such
circumstances, the contribution of other causes of severe anaemia, such as nutrition
and worm infections in the age group considered needs to be properly quantified so that
in the end the effect of the intervention on severe anaemia due to malaria can be
reliably assessed.  When it comes to the cause of malaria deaths, incidence of severe
anaemia rather than mortality rates might serve as a measure of malaria vaccine or
drug effect. 
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Study Goal and Objectives
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2.1 Study Goal
To characterise the epidemiology of Plasmodium falciparum parasites, patterns
of seasonality in infection and morbidity, and their relationship to radical cure in a
rural community in northern Ghana.
2.2 Specific Objectives
 To determine the age-dependent multiplicity of Plasmodium falciparum infections
in the Kassena-Nankana district using the msp2 gene assessed by PCR-RFLP.
 To establish the incidence rate of infections with P. falciparum during the wet
season among semi-immune (18 to 55years) residents in the Kassena-Nankana
district of northern Ghana.
 To establish the incidence rate of new infections with P. falciparum during the
wet and dry seasons among infants/ young children (6-24 months) resident in the
Kassena-Nankana district of northern Ghana.
 To determine if the densities/µL of blood of the incidence rate of first infection with
P. falciparum is greater in the wet (high transmission) season than in the dry (low
transmission) season.
 To determine if the incidence rate of axillary temperature  37.5oC and P.
falciparum densities  20,000 parasites/µL of blood is greater in the wet season
than in the dry season, and whether this impacts on more severe malarial
infections.
 To determine if radical cure places individuals at increased risk of recurrent,
symptomatic malaria during the next 6 months.
 To document the levels of severe anaemia in the wet (high) and dry (low
transmission) seasons among infants/ young children (6-24 months) in the
Kassena-Nankana District.
 To characterise severe anaemia in infants/ young children (6-24 months) in the
Kassena-Nankana District of northern Ghana.
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2.3 Study Area, Population and General Methodology
2.3.1 Study Area
The studies were carried out in the Kassena-Nankana district of northern Ghana. The
district lies within the Guinea savannah woodlands between latitudes 100 30/ and 110 00/
North of the equator and between longitudes 10 00/ and 10 30/ West of the zero
Meridian.  It is located in the Upper East Region of Ghana, shares its northern boundary
with Burkina Faso and covers an area of 1675 km2. The 141,000 resident population is
widely dispersed in roughly 14,000 compounds with a few living in concentrated
settlements in the district capital. The residents are mainly subsistence farmers growing
millet (the staple food), groundnuts, rice and vegetables. They also rear chicken, goats,
sheep and cattle. A few engage in petty trading. There are two main seasons, a wet and
a dry season, the wet season is short with an annual rainfall averaging 800-1000 mm
per annum, occurring mainly between June and September when transmission of
Plasmodium species, mostly P. falciparum by Anopheles gambiae and An. funestus
peaks. The minimum and maximum daily temperatures range between 160C to 450C
respectively. Previous malaria prevalence surveys in children (Binka et al.  1994)
documented rates ranging from 53.3-76.5% at the end of the dry season to a peak of
84.5-94.2% during the wet season. The percentages of the different species of malaria
parasites were 70.6% for Plasmodium falciparum, 16.9% P. malariae, 7.9% P. ovale,
and 1.4% P. vivax. 
The siting of a large irrigation project, which covers an area of 3,860 hectares and 42
kilometres of canals, allows for dry season farming of rice and tomato. There are
roughly 90 dug out dams in addition to this that serve as water sources for the people
as well as livestock during the long dry season. Other parasitic diseases including
lymphatic filariasis and schistosomiasis of both haematobium and mansoni are
therefore frequent and high.
The health facilities in the district comprise of a hospital, four health centres and three
clinics. These are complemented by community-based service delivery. They provide
16
static services while the District Health Management Team (DHMT) operates outreach
clinics, providing maternal and child health services within the district. 
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Figure 2.1 Maximum, minimum (solid dots, dotted lines) or mean (squares, solid line)
monthly rainfall in the Kassena-Nankana District between 1978 and 1995, and monthly
rainfall during 1996 (X) and 1997 (O).
Recent data from the district hospital showed the top four diseases prevalent to be
malaria, acute respiratory infections, anaemia, and gastro-enteritis.  Malaria is the
leading cause of both morbidity and mortality, accounting for 60% of hospital
admissions and 41% of hospital deaths. Data from verbal autopsies coded between
1993 and 1999, document malaria as responsible for 35% of all deaths in children aged
less than five years and 9% of adult deaths. A further 18% of all the deaths are
classified as anaemia deaths and can be attributed to malaria (Ngom, Personal
communication). 
2.3.2 Study population
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The Navrongo Demographic Surveillance System (NDSS) implemented by the
Navrongo Health Research Centre (NHRC), monitors the total population of about
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Participants were then followed prospectively for at least four months with routine bi-
weekly (every other week) thick and thin smears as well as thrice-weekly field worker
interviews of all subjects to determine symptoms or signs of illness. Those developing
symptomatic malaria were treated and observed for clearance of parasitaemia and
resolution of malarial illness. 
The selection procedure in those studies for parasite genotypes and severe anaemia
were the same, but they were carried out as cross-sectional surveys.
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3.1. Abstract
Age dependence of malaria infection was assessed in an age-stratified cluster sample
of 308 individuals from the Kassena-Nankana district of northern Ghana during
June/July 2000. Overall prevalence of P. falciparum by microscopy was 70%, with the
maximum among 5-9 year olds. Parasite density was highest (geometric mean 1,922/µl
blood) in 1-2 year olds. 82% of samples were positive by PCR, and RFLP typing of the
P. falciparum msp2 revealed a mean msp2 multiplicity of 3.4 (range: 1 to 8) genotypes
per PCR positive sample. Multiplicity increased with age until 5-9 years and then started
to reduce again into adulthood. 49.3% of infections belonged to the msp2 FC27 allelic
family and 50.7% to the 3D7 family. On the day of the survey, only 3.6% of the
participants had fever (axillary temperature  37.50C) and 2.3% had fever associated
with parasitaemia. The correlation between parasite density and msp2 multiplicity was
0.42; highest among infants, and decreased with age to a minimum among 5-9 year
olds.  Contrasting with results from Tanzania, this correlation increased with age in
adolescents and adults. Parasite multiplicity is very high in this community, and the
patterns of age dependence are similar to those in other holoendemic sites in Africa,
validating the use of the age-multiplicity relationship as an indicator of malaria
endemicity.
3.2. Introduction
In endemic areas, the number of clones of malaria parasites co-infecting a single host
can be a useful indicator of the level of transmission and/or the immune status of the
host.  Increase in transmission levels (EIRs) is generally associated with progressive
increases in the average number of malaria parasite clones per host (Arnot, 1998);
(Babiker et al.  1999) and malariometric surveys have documented falciparum
multiplicity of up to 9 different parasite clones at a given time in a single asymptomatic
host (Felger et al.  1994); (Engelbrecht et al.  2000).  This is almost certainly an
underestimate because of technical limitations (Farnert et al.  2001). 
In areas of very high transmission, multiplicity is age dependent, with the highest values
reached in young children (Smith et al.  1999b); (Ntoumi et al.  1995), (Konate et al. 
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1999).  However, studies in areas of lower endemicity: Ndiop in Senegal (Zwetyenga et
al.  1998); Riboque in Sao Tome (Muller et al.  2001), The Gambia (Conway, 1991),
Sudan (Babiker, 1998),  reported little or no influence of age on infection complexity and
allelic distribution in P. falciparum infections.
Multiplicity of infection also affects both the prevalence of parasite genetic markers such
as those involved in resistance to anti-malarial drugs (Jelinek et al.  1999), (Schneider
et al.  2001) and the risk of clinical disease.  Inverse relationships between multiplicity of
infection and clinical malaria (Al Yaman et al.  1997); (Beck et al.  1997); (Contamin et
al.  1996) have been found in older children in holoendemic malarious areas, while
positive relationships between multiplicity and clinical attacks have been observed in
areas of lower transmission (Zwetyenga et al.  1998); (Roper et al.  1996); (Ofosu-
Okyere et al.  2001). 
The relationship between multiplicity of P. falciparum infection and parasite densities
may also be a useful indicator of immune status, since it can indicate the extent to
which different parasite clones are controlled independently of each other (Smith et al.
1999a).  High correlations have been reported between parasite density and multiplicity
of infection in infants and young children but not in older individuals (Ntoumi et al.
1995); (Smith et al.  1999b);(Engelbrecht et al.  2000). 
The Kassena-Nankana district (KND) in northern Ghana has been well characterised as
a highly endemic malarious area (Binka et al.  1994); (Owusu-Agyei et al., 2001), (Baird,
2001)], with plans to embark on clinical studies including testing of malaria vaccines.
We have now carried out a study of the age dependence of multiple infections in KND
and the patterns of relationship between multiplicity and other variables (age, sex, and
parasite density), using the highly polymorphic merozoite surface protein 2 locus (msp2)
of P. falciparum as marker gene. We then examined how the KND compares with other
malaria endemic areas in terms of these variables.  The results will be of value for the
design of clinical trials using molecular typing results as outcomes.
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3.3. Materials and Methods
Study site: This work was carried out in the Kassena-Nankana District (KND) located in
the north-eastern part of Ghana, bordering Burkina Faso. The site is served by the
Navrongo Health Research Centre (NHRC), which uses the Navrongo Demographic
Surveillance System (NDSS) to monitor the population dynamics of the district (Binka et
al., 1999).  The district has a human population of about 141,000 living in roughly
14,000 compounds, mostly dispersed in rural areas.  About 20,000 people live in
Navrongo town, the administrative capital.  Most people live in compounds of mud
bricks, roofed with mud, thatch, or in a few cases, corrugated iron sheets. The main
occupation is subsistence farming, with millet and sorghum grown around their
compounds and small herds of livestock. The average annual rainfall is 850-950 mm,
almost all in the months of May to September. The average annual temperature ranges
from 16oC to 45oC. Water for mosquito breeding is available all year round due to the
siting of a large irrigation project in the district (Irrigation Company of Upper Regions,
2001). Average P. falciparum malaria transmission levels (EIR) of 300 infective bites per
person per annum have been documented. The main vectors incriminated are
Anopheles gambiae s.l. (both An. gambiae s.s. and An. arabiensis and An. funestus
(Appawu et al.  1994); (Binka et al., 1997). P. falciparum infection in KND shows
seasonal peaks and troughs in prevalence (Binka et al.  1994) and clinical malaria
incidence (Baird et al., 2001), with an incidence density of infection of 5 cases per
person-year in the dry season to as high as over 7 cases per person-year in the wet
season.
Study design: The malariological survey was carried out during June and July 2000,
which mark the beginning of the rainy season. A cluster sample of the population of
KND was drawn by selecting sixteen "index" compounds at random from the 14,000
within the district, making use of the NDSS. From each "index" compound, 2 people in
each of the following age categories were selected; <1; 1-2; 3-4; 5-9; 10-19; 20-39; 40-
59; 60+. Volunteers were recruited sequentially into each age category until the required
number was made up. In some cases, additional people insisted on participating in the
survey. Where necessary, participants were recruited from the nearby compounds in
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order of proximity to the "index" compound. A period of one month was required to visit
all the clusters. 
Participants converged at the "index" compound of each of the clusters following an
appointment. A signed/thumb-printed individual informed consent was obtained in their
local language, followed by completing of a participant data form with a study
identification number. Axillary temperature was recorded for all participants. Thick and
thin blood films and DNA Isocode stix were prepared from all the participants, as well as
an instant haemoglobin concentration determination using an automated haemocue
machine (Haemocue Lee Diagnostics Inc. system). 
Laboratory methods: Blood slides were dried, the thin films fixed with methanol and both
stained with Giemsa. These were later analysed by light microscopy. Parasite density
was assessed by counting the number of parasites per 200 leukocytes in an oil
immersed thick film (using a microscope with X100 objective and X 10 eyepiece). A
sample was considered negative only after 200 high powered fields had been read
without parasites. Parasite counts were converted to parasites per µl blood assuming an
average of 8000 leukocytes per µl blood. 
Deoxyribonucleic acid (DNA) was extracted from all samples collected on DNA-Isocode
stix irrespective of microscopy results and the msp2 gene of P. falciparum was
genotyped by the Polymerase Chain Reaction- Restriction Fragment Length
Polymorphism (PCR-RFLP) approach of (Felger et al.  1999). Restriction digests of the
PCR products were performed with Hinf1 and Dde1, and the restriction fragments
separated by gel electrophoresis.  Individual clones were identified by allele-specific
patterns. Up to 8 different clones can be distinguished by this method (Felger et al.
1999).
Statistical methods: Population parameters were estimated as weighted averages of the
age-specific values weighed in proportion to the total district population in the age
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group. The SAS GENMOD (SAS Institute Inc., 1996) procedure was used to compute
confidence intervals, allowing for the clustering.
3.4. Results
Three hundred and eight residents of the Kassena-Nankana district participated in the
survey. Their ages ranged from less than two weeks to 84 years. 53% of participants
were female (Table 3.1).
Table 3.1: Baseline Characteristics of participants
  Age
Group
Years
Total
Pop'n
    %
Cohort
No  ( %)
Gender**
No  (%)
  
          GMPD
Prevalence of P. falciparum
Microscopy               PCR
No.   (%)            No.    (%)
   < 1    4.0 31  (10.1) 14  (45.2)   726(CL:318-1659) 16  (51.6) 19     (61.3)
    1-2    4.5 34  (11.0) 19  (55.9) 1922(CL:806-2901) 29  (85.3) 28     (82.4)
    3-4    4.4 34  (11.0) 19  (55.9) 1903(CL:837-2999) 29  (85.3) 33     (97.1)
    5-9  12.9 39  (12.7) 17  (43.6)   862(CL:518-1607) 34  (87.1) 38     (97.4)
 10-19  23.3 51  (16.6) 30   (58.8)   306(CL:132-433) 39  (76.5) 48     (94.1)
 20-39  23.0 42  (13.6) 26   (61.9)   117(CL:86-188) 29  (69.0) 31     (73.8)
 40-59  17.6 37 (12.0) 17   (45.9)   153(CL:91-312) 18  (48.6) 25     (67.6)
    60+  10.1 40  (13.0) 20  (50.0)   174(CL:104-243) 23  (57.5) 30     (75.0)
** Gender, female to male = (53%/47%) ; GMPD = Geometric Mean Parasite Density
PCR = Polymerase Chain Reaction
By microscopy, 217 (70.5%) of the samples were infected with Plasmodium falciparum,
16 (5.2%) with P. malariae, 1 (0.3%) P. ovale and 2 (0.6%) P. vivax. The prevalence of
P. falciparum infection was highest among children 5-9 years, followed closely by those
3-4 years and 1-2 years of age, all these groups registering over 80% infection rates.
The all age parasite rate of P. falciparum in the population, allowing for the age
stratification of the sample was 69.1%. Infection rates generally decreased with age in
individuals who were older than 10 years of age. The Geometric Mean Parasite Density
(GMPD) (for microscopy positive slides only) was highest (1,922/µl blood; 95% CI: 806-
2,901) in children 1-2 years of age, followed closely by children between 3-4 years
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(1,903/µl blood; 95% CI: 837-2,999). A steady decrease was observed with increasing
age to a GMPD of only 117/µl blood (95% CI: 86-188) in adults from 20 years of age
onwards [Fig. 3.1]. There was a tendency of increasing GMPD in adults from 40 years
of age and above. 
GMPD (Geometric Mean Parasite Density) = graph with solid squares; 
Mean multiplicity = graph with solid dots.
Figure 3.1. P. falciparum parasite GMPD and Mean Multiplicity of infection
By PCR analysis, 252 (81.8%) were positive for Plasmodium falciparum.  Twelve of
those classified as microscopy positive were negative by PCR. This gave a microscopy-
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Figure 3.2. Sensitivity of microscopy
sensitivity of 81.3% and specificity of 78.6% compared with PCR (as the Gold
standard). PCR positivity increased from a minimum of 61.3% in children under 1 year
of age up to 97.4% in children between 5-9 years (Fig. 3.2) and decreased somewhat
with age after the age of 19 years.  The logistic regression indicated that the sensitivity
of microscopy decreased with age (likelihood ratio X21 = 8.8, p= 0.003).
All the 252 samples found to be PCR positive were analysed by RFLP. In total, 864 P.
falciparum clones were detected; 426 (49.3%) belonged to the FC27 allelic family while
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438 (50.7%) belonged to the 3D7 allelic family. The mean msp2 multiplicity of infection
was lowest among children less than one year of age. This increased steadily with age
until 5-9 years and then started to reduce with age [Fig. 3.1]. The overall mean msp2
multiplicity of these samples was 3.4, with a range of 1 to 8 clones per isolate (Fig. 3.3).
Mean multiplicity of infection in isolates found to be microscopic positive was much
higher (3.7, se = 0.1 clones per infection) than in isolates which were microscopically
negative (2.4± 0.3 clones per infection). Only 16% of those with malaria infection had
single infections. Of these, 38% were children < 5years and 58% were 18 years and
above. Children between 5 and 17 years were almost exclusively infected with multiple
clones. 
       Figure 3.3. Frequency distribution of multiplicity of infection
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Eleven (3.6%) of the participants had documented fever (axillary temperature  37.50C).
Seven of these fevers were associated with parasitaemia, 6 of them detected by
microscopy. 
The Spearman's Rank Correlation between P. falciparum parasite density and msp2
multiplicity of infection was 0.42. When this correlation was assessed separately by age
group (Figure. 3.4), it was observed to be highest (0.66) among infants, decreasing
gradually until it was lowest (-0.11) by the age of 5-9 years. A steady rise was observed
again from 10-19 years and this continued to a high of 0.5 among the participants of
age 60 years or more. 
Figure 3.4. Correlation of msp2 multiplicity of infection and falciparum parasite density
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3.5. Discussion
Molecular analysis of parasites collected in this survey in the Kassena-Nankana (KND)
demonstrates that parasite multiplicity is very large in this community, with most
asymptomatics carrying multiple P. falciparum genotype infections. The multiplicity of
infection seen in the KND was comparable with other holoendemic malarious areas
such as in the Kilombero district in Tanzania (Hill et al.  1995); (Smith et al.  1999c)];
Agunu in Nigeria (Engelbrecht et al.  2000); Dielmo in Senegal (Ntoumi et al.  1995);
(Trape et al.  1994). This multiplicity was higher than in areas with lower transmission,
such as The Gambia (Conway, 1991); coastal Kenya (Kyes et al.  1997); (Mbogo et al.
1995); Darawesh in Sudan (Babiker, 1998).  However, P. falciparum multiplicity is not
directly proportional to intensity of transmission (as measured by EIR).  
Table 3.2: Relationship of frequency of multiclonal infections of P. falciparum and
entomological inoculation rate in comparison with other African countries.
Country Entomological
inoculation rate
No. of clones
per isolates 
Frequency of
multiclonal infection
References
Ghana (KND)       300 3.4 (1-8) 0.84
The Gambia       2-4 2.34 (1-4) 0.5-0.6 1,2,3
Senegal   100-200 3.9-4.8 (1-6)  0.82 4, 5
1.9-2.3 (1-4) 0.15 6
Nigeria        - 3.9 (1-9) 0.18 7
Sao Tome        - 2.4 (1-6) 8
Tanzania       >500 3.29 (1-6) 0.85 9, 10
Kenya       0.1-26.7 2.1 (1-4) 0.70 11,12
Sudan       0.6 1.3 (1-3) 0.20 13
 Mean (range in parentheses)
 all ages (2 weeks to 84 yrs)
 children
 Adults
 References: 1. Carter & McGregor, 1973; 2. Hill &  Babiker, 1995; 3. Lindsay et al., 1989; 4. Ntoumi et
al., 1995; 5,6. Trape et al., 1994; 7. Engelbrecht et al., 2000; 8. Muller et al. 2001; 9. Hill et al., 1995; 10.
Smith et al., 1993; 11. Kyes et al., 1997; 12. Mbogo et al., 1995; 13. Babiker et al., 1997.
The KND results fit in with a general pattern that incidence of infection appears to
increase with EIR up to approximately one bite from a sporozoite-carrying mosquito per
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adult per night but that higher levels of transmission do not result in a correspondingly
higher incidence (Charlwood et al.  1998). Including the KND data in the plot relating
multiplicity and EIR given by Arnot (1998) goes to support his view that increasing EIRs
lead to progressively smaller increases in the average number of clones per host (Table
3.2).
The almost equal proportion of FC27 (49%) alleles compared with 3D7 (51%) alleles
documented in the KND is similar to results of most other studies. Examples include
studies in Kilombero, Tanzania (Felger et al.  1999), Ndiop in Senegal (Zwetyenga et al.
1998), The Gambia (Conway, 1991) and Papua New Guinea (Felger et al.  1994). The
similarity in the diversity of msp2 in KND to that in other sites goes to confirm the
suggestion by (Felger et al.  1999) that though the genetic diversity is extensive, it is
limited by structural constraints or immune selection. However, different proportions of
the two allelic families have been observed in studies carried out in Dielmo in Senegal
(Ntoumi et al.  1995); (Ntoumi et al.  1997) and in Sao Tome (Muller et al.  2001).
Ntoumi et al.  (1997), attributed this difference to the high frequency of recombination in
Dielmo. However, the levels of transmission are similar in Dielmo and KND, so there is
no reason why recombination should be more frequent in Dielmo than in KND. 
As in many other malarious areas, children under 10 years were the most infected.  The
highest GMPD in KND was in children under 4 years of age, similar to other
holoendemic areas (Trape et al.  1994); (McElroy et al.  1994); (Smith et al.  1999b).
The earlier peaks of malaria prevalence, 2-5 years and multiplicity 3-7 years, (Smith et
al.  1999b), reported among Tanzanian children in Kilombero district compared to those
in the KND (5-9 years) can be explained by the perennial nature of malaria transmission
in the Tanzania site.  As in KND, the peak in multiplicity was also found in the 5-9 year
age group in Dielmo, Senegal, (Konate et al.  1999), where transmission is of similar
seasonality and intensity to KND. The reduction in multiplicity of infection observed after
age 10 in this study was observed in both these other holoendemic sites (Ntoumi et al.
1995); (Ntoumi et al.  1997); (Smith et al.  1999b).  One possibility is that this could
reflect specific anti-parasite immunity acquired after about 10-15 years of age in
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holoendemic areas (Ntoumi et al.  1997). However it could also be due to lower
detectibility by PCR at low densities. 
The peaks in multiplicity and density in KND are in different age groups, just as they are
in Dielmo and in Kilombero.  Moreover there is no peak in multiplicity in lower
transmission areas although parasite densities can show age dependence there (e.g.
Muller et al.  2001).).  The mechanisms controlling multiplicity of infection and parasite
densities follow different age-profiles and must therefore be different.  Further evidence
for this is provided by the age profile of the correlation between parasite density and
multiplicity.  In Kilombero there was a gradual loss of the correlation between parasite
density and multiplicity with age (Smith et al.  1999b). This age profile matched that of
the acquisition of clinical immunity.   In contrast, correlation between multiplicity and
parasite density was observed in all age groups in Sao Tome (Muller et al.  2001),
where there is slower acquisition of clinical immunity. In a meso-endemic area in
Uganda this correlation showed different age patterns with msp1 from that with typing of
the allelic families of msp2 (Peyerl-Hoffmann, 2001).
In KND the pattern in children less than 10 years old matched that in the Tanzanian
study.   We suggested in the Tanzanian study that the loss in correlation between
multiplicity and density could be explained by gradual acquisition of pan-specific
immunity controlling parasite densities.  In older individuals in KND however, we
observed a steady and gradual increase (from this minimum) in the correlation between
multiplicity and parasite density after the age of 10 until over 60 years of age.   One
explanation for this could be that, given the very low densities observed in older
participants and the diversity of the parasites, the multiplicity might simply be counting
the number of individual parasites in the sample.   The existence of a correlation
between multiplicity and density could then be an indication of accurate quantitation of
low-density parasitaemia. 
Considering the fact that the two methods were applied independently and blind, there
was also a very high level of agreement between microscopy and PCR for positivity for
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P. falciparum. This validates the parasitological data reported in the past in studies
carried out in the Kassena-Nankana district in northern Ghana using the same
microscopy techniques.   As in other studies (Trape, 1985); (Muller et al.  2001), the
positive samples that were missed by the microscopists had significantly lower mean
multiplicity of infection than the average and were predominantly in older individuals
who generally have very low parasite densities. 
A further strength of the study is that it was based on a random cluster sample of the
whole district population, drawn from the NDSS.  This made it possible for us to ensure
that adequate numbers of individuals were allocated to each of the age groups and also
to make estimates of population parameters allowing for the different sampling fraction
in each age group.
Malaria transmission in the KND can be stratified into areas close to and under the
direct influence of the rice irrigation project and areas further away and indirectly
influenced by the irrigation project. Though a slightly higher multiplicity was observed
among the individuals living in communities closer to the irrigation project, this
difference was not significant. This tendency can be explained by the higher
inoculations experienced in the irrigated areas where mosquito-man contact is high all
year round compared to non-irrigated areas in the dry season. Non-significant
differences in multiplicity between individuals close to the irrigated areas and those far
can also be explained with the belief that increasing EIRs lead to progressively smaller
increases in the average number of clones per host. 
The present study constitutes the baseline of a longitudinal study designed to collect
parasitological data at eight weeks intervals from individuals of all age groups over a
period of one year. At the beginning of the wet season, the data from the Kassena-
Nankana district in northern Ghana has demonstrated one of the highest multiplicity with
age dependence patterns similar to those in other holoendemic sites in Africa, thus
validating the use of the age-multiplicity relationship as an indicator of malaria
endemicity. However, the age-patterns of multiplicity could differ significantly in the dry
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season especially in the non-irrigated areas of the district.   Data from the additional
surveys will allow us to build upon this baseline and contribute to our knowledge and
understanding of the seasonal dynamics and multiplicity of infections in all age groups
in this area of highly seasonal holoendemic malaria.
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4.1. Abstract
Adult residents of holoendemic malaria regions in Africa have a naturally acquired
immunity (NAI) to malaria that renders them more resistant to new infections, limits
parasitaemia, and reduces the frequency and severity of illness.  Given such attributes,
it is not clear how one might evaluate drug or vaccine efficacy in adults without serious
confounding.  To determine symptomatic and asymptomatic malaria attack rates in
adults of northern Ghana, 197 men and women underwent curative therapy for any
existing malaria infection at the start of the wet (high transmission) season. They were
monitored for first parasitaemia and first clinical episode of infection by Plasmodium
falciparum over 20 weeks (May-Oct., 1996).  The cumulative incidence of primary
infection by Plasmodium falciparum was 0.98 and incidence density of infection was
calculated to be 7.0 cases/person-year.  Symptoms were reported by 19.5% of
individuals at the time of first recurrent parasitaemia.  Incidence of infection, parasite
density, and the frequency of symptoms were comparable in males and females.  The
results show that NAI provided these adults with no defence against rapid re-infection
and suggest that this population-infection design could serve to demonstrate the
efficacy of a drug or vaccine in preventing parasitaemia.
4.2 Introduction:
Malaria is one of the leading causes of morbidity and mortality in the tropics, affecting
individuals of all ages, but primarily very young children and pregnant women (World
Health Organisation, 1997a). Integrated approaches against both the parasites and
vectors are required to control this disease with vaccines offering the best hope for
sustained control in areas of intense transmission (Miller et al.  1998); (Hoffman, 1996).
Malaria morbidity in adult Africans has long been considered of minor importance
(Wilson, 1950) because adult residents of holoendemic areas have usually developed
high levels of protective immunity as a result of their long and continuous exposure to
malaria infections.  The two forms of immunity described are (i) an anti-disease
immunity, that allows one to carry parasite loads without symptoms; and (ii) an anti-
parasite immunity, that is responsible for a marked reduction of parasite densities after
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a certain age (Daubersies et al.  1996); (Trape et al.  1994); (Day et al.  1991). Malaria
slides from adults in highly endemic areas are usually positive regardless of the clinical
context (Trape, 1985) and adults are known to become rapidly re-infected with malaria
parasites after treatment (Hoffman et al.  1987). Appropriate criteria for deciding when
adults should receive treatment for malaria have never been agreed upon.  It has been
variably suggested that treatment should be based on parasite density threshold,
(Rogier et al.  1996); febrile condition, (Rougemont et al.  1991); (Smith et al.  1995);
symptom history, (Bassett et al.  1991) or an association between symptom history and
parasitaemia (Mkawagile et al.  1986); (Stein et al.  1985). 
The present study was conducted to measure the incidence and features of
symptomatic and asymptomatic infection by Plasmodium falciparum in malaria-immune
adult Ghanaians that had been radically cured of all pre-existing Plasmodium infections.
Effort was made to study newly incident infections in comparably sized cohorts of males
and females, 18-55 years old, who were lifetime residents of the Kassena-Nankana
district of northern Ghana.  This study was conducted during the peak malaria
transmission season in order to characterise malaria in the area and to provide the
foundation data needed for valid and efficient design of malaria vaccine and anti-
malarial drug trials in the region. 
4.3 Subjects and Methods
Study Site and Population:  The Kassena-Nankana district (KND) lies within the Guinea
savannah woodlands between latitudes 10º 30’ and 11º 00’ north and between
longitude 10º 00’ and 10º 30’ west .  It is located in the upper Northeast region of Ghana
at its border with Burkina Faso.  The KND has an area of 1,675 km2 and a population of
141,000 living in roughly 14,000 dispersed compounds.  The main occupation is
subsistence farming of predominantly millet and livestock.  The KND has a mean
monthly temperature range of 16ºC to 45ºC and rainfall averages 800-1,000 mm per
annum, occurring mainly between May and October.  Malaria transmission by
Anopheles gambiae and An. funestus peaks at the close of wet season, during October-
November.  Malaria parasite prevalence among children <5 years in the KND was
40
significantly greater in the wet season [May - Oct.] than in the dry season [Nov. - Apr.]
(Binka et al.  1994).  Malaria is the leading diagnosis of illness in the district hospital,
accounting for 60% of all admissions and 41% of hospital deaths (Ministry of Health,
1996). 
Subject Selection and Consent: A representative sample population of adult men and
non-pregnant women between the ages of 18 and 55 years was sought. The sample
was randomly selected using the Navrongo Demographic Surveillance System (NDSS)
a longitudinal census of all district residents that is updated every 3 months (Binka et
al., 1999).  We tallied the total number of eligible adults (48,032) within the 5 geographic
zones of the district and randomly selected 16 "index" compounds, with selections
weighted by population size.  Chiefs, elders, and potential subjects were then visited,
the research work explained and discussed, and opinions sought before enrolment.
Translation, narration, discussion, and communal consent were the essential elements
of the informed consent process.  
Enrolment and Screening:  The screening process involved clinical history, vital signs,
physical examination by a physician, collection of 1.0 ml venous blood for malaria
smears, and haematology screening.  Urine was collected from all women for -HCG
pregnancy testing.  Laboratory screening involved microscopy of Giemsa-stained thick
and thin blood smears, haemoglobin testing, and qualitative testing for Glucose-6-
phosphate dehydrogenase deficiency (G-6-PD).  Remaining blood and plasma were
archived for future laboratory work.  Specific exclusion criteria were pregnancy, allergic
reaction to antimalarial drugs, and illness or a condition requiring hospitalisation.  
Curative Therapy of Malaria:  Just prior to the start of the rainy season (Apr. 1996)
radical curative therapy was employed to achieve complete clearance of any patent,
dormant, or incubating malaria infection from blood and liver.  Volunteers were treated
with oral quinine sulphate (650 mg three times daily for four days) followed by
doxycycline, (100mg twice daily for 10 days). Subjects testing normal for G-6-PD
(NADP+ spot test, Sigma Chemical Co., St. Louis, MO) received primaquine (0.5 mg
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base per kilogram body weight once daily for 14 days.  Nineteen (19) subjects who
tested G-6-PD deficient received only quinine and doxycycline treatment.  All doses
were supervised and directly observed over the 18 days of radical curative or 14 days of
curative therapy.
Surveillance and Referral:  Routine blood films were obtained on day 15 of  the initial
treatment and were repeated at two week intervals for the duration of the study (20
weeks) by trained fieldworkers permanently residing in each of the 16 compound
clusters.  Fieldworkers visited subjects three times weekly at their homes to inquire of
their general health and check for fever by measuring axillary temperature.  Each visit
began with a direct question: “Have you been sick since the last visit?”  If the answer
was no, the interview ended.  If the answer was yes the subject was asked to describe
his or her symptoms and these were recorded.  If a subject complained of current illness
to the fieldworker or had an axillary temperature 37.5 0C, a non-routine blood film was
obtained. Subjects were transported to the district hospital where the blood smear was
examined by an expert malaria microscopist.  Based upon presenting signs, symptoms
and microscopy results, physicians decided upon a treatment plan.  
Study end points, treatment and follow-up: The two primary outcome variables in this
study were: (1) time to primary post-cure parasitaemia, and (2) time to first episode of
parasitaemia associated with clinical symptoms.  Blood slides were prepared as
Giemsa-stained thick and thin smears examined by 1000 X light microscopy using oil
immersion.  Parasitaemia were scored per microlitre of blood by counting the number of
asexual parasites per 200 white blood cells, assuming 8,000 white blood cells per
microlitre, and multiplying the parasite count by 40.  A slide was considered negative if
no parasites were observed within 200 high power fields. 
Our working diagnosis of clinical malaria was a patent asexual stage parasitaemia
accompanied by any one or more of the following symptoms: fever, headache, chills,
myalgia, dizziness, nausea, diarrhoea.  All symptomatic subjects with microscopy-
confirmed malaria were promptly treated with Chloroquine diphosphate (25mg base/kg
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body weight over 48 hours) and monitored for outcome.  Chloroquine failures were
treated with 3 tablets of Fansidar® (Sulphadoxine 500 mg + Pyrimethamine 25mg,
Hoffman-La Roche). 
Data handling and analysis:  Cumulative Incidence (CI), expressed as the risk of an
outcome and/or probability of infection during the 20 weeks, and Incidence Density (ID),
which estimates new infections per unit of person-time at risk were used as quantitative
tools in determining the frequency of newly incident Plasmodium infections in this
cohort.  Owing to the pre-erythrocytic stage incubation period of the parasite, the first 10
days following curative therapy were excluded from analyses as risk-free person-time.
To identify predictors of a positive blood slide, and to determine whether the use of
specific complaints or combinations of complaints significantly increased the likelihood
of correctly predicting a positive blood smear, we used logistic regression models that
fitted parasite positivity against symptoms recorded. 
4.4 Results
The study plan is chronologically depicted as a flow diagram in Figure 4.1.  During the
initial radical or curative therapy stage, 98.7% of the 16,758 drug doses were
administered and witnessed with only one volunteer dropping out.  The baseline
characteristics of the enrolled study population that completed radical or curative
treatment and contributed person-time and/or study endpoints are presented in Table
4.1.  The mean age, weight, and haemoglobin concentration among females was
significantly different from that of males; older age possibly an artefact that arose from
the necessity of restricting female enrolment to those not pregnant or nursing.  Patent
malaria infections were identified in 110 of 197 (55.8%) subjects at enrolment and
Plasmodium falciparum accounted for 102 of the 110 (92.7%) malaria infections, the
remaining 7.3% due to infections by P. malariae (7) and P. ovale (1).
Gametocytes were observed in 29.6% of these subjects.
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37 symptomatic
(20%)
153 asymptomatic
(80%)
190 primary P. falciparum infections 3 subjects consistently aparasitic 4 negative early drop-outs
197 complete radical cure & commence
20 week follow-up for symptoms & parasitemia
198 qualify, enrolled, & start 18 day radical cure
256 informed consenting screened for Hb,
serious illness, pregnancy, G-6-PD, malaria
300 adults, 18-55 years randomly selected
 & invited from 4 zones (16 clusters)
Kassena-Nankana District, N. Ghana
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Figure 4.1: Study Plan.
Glucose-6-phosphate dehydrogenase deficiency (G-6-PD) was detected in 19 of the
197 (9.6%) enrolled subjects (7.1% of women vs 11.6% of men, P = 0.28).  Baseline
malaria prevalence was significantly greater among males (58% vs. 38%, P = 0.01).  All
subjects belonged to the two main ethnic groups (Kassim, Nankam), in near balanced
numbers, and had lived their entire lives in the area. 
Blood smear screening on day 15 following the start of radical or curative therapy
demonstrated parasite clearance in all subjects.  The first infections thereafter were
identified during week 3 of post-cure follow-up.
Table 4.1.  Baseline characteristics of the Ghanaian study population*.
Characteristic Males Females P value
No. subjects (%) 112  (56.8) 85  (43.1) -----
Mean Age (yrs) (95% CI) 35.4 (33.3 - 37.5) 43.3 (41.3 – 45.2) < 0.01
Mean Weight (kg) (95% CI) 57.4 (56.0 – 58.8) 50.3 (49.0 – 51.6) < 0.01
Mean Hb level (g/dL) (95% CI) 12.1 (11.8 – 12.4) 10.8 (10.3 – 11.2) < 0.01
No. P. falciparum positive (%) 64  (57.1) 33 (38.8) 0.01
GM parasitaemia/L (95%CI) 135 (103 - 177) 98 (78 - 123) 0.07
No. Febrile (%) 2  (1.0) 1  (0.5) -----
 * CI = confidence interval; Hb = haemoglobin; GM = geometric mean.
The cumulative incidence of primary P. falciparum infection over the 20 weeks following
cure are plotted for males and females in Figure 4.2.  Both sexes demonstrated the
most profound rise in new infections during weeks 5 to 10, when the CI rose from 0.22
in males and 0.21 in females to respectively 0.81 and 0.77.  Three subjects remained
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consistently aparasitic to the 20-week endpoint.  Four others dropped out of the study,
negative, at various earlier time points.  The collective 20-week CI for P. falciparum
infection in adults was 0.98.  The respective 20 week wet season IDs for infection in
males and females was 7.2 and 6.7 (RR = 1.07, 95% CI: 0.70, 1.24) infections/person-
year.  The CI of illness coincident with parasitaemia during this period was 0.42 among
males and 0.49 among females (Fig. 4.2).  Analysis by location (Fig. 4.3) found the
acquisition of primary infection to be most rapid in the western compounds and slowest
in the south (mean time to infection: West, 7.2 weeks vs. South, 8.7 weeks, P = 0.03).
Mean time to the first episode of confirmed symptomatic malaria was similar among the
four locations studied.
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Figure 4.2.  Cumulative incidence of post-curative primary infection and primary
symptomatic infection by P. falciparum in adult males and females.  Wet season (May-
Dec., 1996), northern Ghana.
Table 4.2 presents the characteristics of these primary infections in male and female
subjects over the 20-week period.  There were no statistically significant differences
between sexes for either CI, ID, the frequency of symptomatic primary infections, or the
GM density of parasitaemia.  Irrespective of sex, adults experienced a 20 week wet
season ID of 7.0 (95% CI: 5.1, 6.8) new P. falciparum infections per person-year of
exposure.  There were 4 females (4.7%) and 3 males (3.6%) who did not develop a
detectable parasitaemia during their 8 to 20 week participation.  All were G-6-PD
normal.
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Figure 4.3.  Cumulative incidence after radical cure of primary Plasmodium falciparum
infection by location in the Kassena-Nankana District of northern Ghana during the wet
season (May-Dec., 1996).
One of these subjects was infected with P. falciparum at enrolment, two others with P.
malariae, and 6 of the 7 made voluntary clinic visits for diagnosis and treatment of
illness during the study period.   Analysis by age, which divided the population into two
near equal groups, < 40 years (n = 100) and > 40 years (n = 97), revealed that mean
times to parasitaemia and symptomatic parasitaemia in the older age group were both
significantly delayed (P < 0.01) relative to those of the younger group (Fig. 4.4).  As a
result, wet season ID in the older group was 5.8 infections/person-year compared to 7.1
in the younger group (P = 0.17).  Parasite densities at infection and at the time of
symptoms were similar in the two groups.
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Table 4.2.  Characteristics of first infections with P. falciparum after radical cure in adult
male and female study subjects during the wet season (May-December, 1996) in
northern Ghana*.
Characteristic Males Females P value
Person-weeks at risk 777 629 -----
No. with primary infections/total subjects (%) 109/112 (97.3) 81/85 (95.3) 0.45
No symptomatic at 1st +ve slide/total +ve subjects (%) 22/109 (20.2) 15/81 (18.5) 0.77
Cumulative Incidence/20 wks wet season 0.99 0.97 -----
Incidence Density/ person-year 7.3 6.7 0.56
GMPD/L 1st appearance, asymptomatic (95% CI) 129(96, 169) 162(118, 223) 0.27
GMPD/L 1st appearance, symptomatic (95% CI) 451(171, 1190) 347(131, 921) 0.72
*GMPD = Geometric mean parasite density; CI = Confidence Interval; 1st = first; wks = weeks; 
+ve = positive 
There were 190 primary, post-cure infections by P. falciparum during the 20 weeks
following cure.  Symptoms and physical complaints characterised the first appearance
of parasites in 37 of these 190 (19.5%) infections. Comparable proportions of males and
females were symptomatic at this first parasitaemia.  (males: 22/109 = 20.2%; females:
15/81 = 18.5%).  Fever was present in 8 of the 37 (21.6%) primary infections that
presented with clinical illness, but was not associated with the level of parasitaemia.
Among individuals with asymptomatic primary parasitaemia who were not treated,
asexual stage parasites were variably present in subsequent follow-up slides.
Parasitaemia was detected in 65% of 566 follow-up slides from 113 representative
subjects and usually not detected over more than 3 consecutive examination dates.
During the course of study time applied to the 153 infected-asymptomatic volunteers,
there were 242 occasions, judged to be clinical malaria on the basis of signs and
symptoms, that prompted blood smear examination.  Asexual stage parasites of P.
falciparum were present at 62 of these 242 occasions and those of P. malariae were
present in one case.  Asexual stages of P. falciparum were thus associated with 99 of
279 cases of malaria-like illness in these previously cured adults.  
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Parasitaemia only Parasitaemia and symptom
Figure 4.4.  Mean time to primary infection by P. falciparum and primary symptomatic
infection by age group in adult Ghanaians.  Error bars indicate 95% confidence intervals
The frequencies of specific complaints/symptoms associated with these infections are
plotted against those of 180 other cases where parasites were undetected (Fig. 4.5).
The frequency of vertigo, chills, and headache were significantly greater among those
with a confirmed parasitaemia.
 Stepwise logistic regression that was applied to the data revealed dizziness and
myalgia as potential (P < 0.1) predictors of a positive blood slide, while diarrhoea was
unrelated. This approach showed dizziness and myalgia to be directly linked to
parasitaemia, with diarrhoea independent of all other variables.
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Figure 4.5.  Comparative physical complaints/symptoms reported by adult Ghanaians
with positive or negative malaria blood smears. * Indicates a statistically significant
difference between groups.
The other reported symptoms; chills, nausea, headaches and fever independent of the
parasitaemia given a presentation of dizziness and/or myalgia.  Patients who reported
chills or nausea were likely to also report dizziness or myalgia but rarely both.
Headache and fever were independent of the other symptoms given the presence of
chills. 
Table 4.3 presents the range and geometric mean densities of primary post-cure P.
falciparum parasitaemia that were measured in symptomatic and asymptomatic cases.
Relatively low-density parasitaemia characterised more than 85% of the infections and
were associated with physical complaints.   The density of asymptomatic parasitaemia
at first appearance of infection was no different than the density of parasitaemia later
associated with the first occasion of clinical illness following curative treatment.  There
were no significant differences between sexes, or between symptomatic and
asymptomatic cases in the frequency of high parasitaemia or in the GM densities of
parasitaemia.
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Table 4.3.  Range and geometric mean densities of first Plasmodium falciparum 
infections after radical cure in adult Ghanaians.
Asymptomatic SymptomaticParasitaemia
Range/L of blood Males Females Males* Females‡
< 2,000/ 82 64 40 46
2,000 – 9,999/L 3 1 3 5
10,000 – 19,999/L 2 0 2 0
> 20,000/L 0 1 2 1
Combined 87 66 47 52
GM parasitaemia/L
(range)
129(40-12,560) 162(40-31,640) 199(40-97,680) 200(40–22,000)
*Males: 22 symptomatic at first positive slide; 25 of 87 others (initially asymptomatic-positive) later
became symptomatic-positive); ‡Females: 15 symptomatic at first positive slide; 37 of 66 others (initially
asymptomatic-positive) later became symptomatic-positive)
4.5 Discussion
The results of this study show that wet season malaria transmission in the Kassena-
Nankana district of northern Ghana is intense and that the incidence of infection and
clinical illness associated with malaria in adults is virtually identical in males and
females. Despite a natural immunity derived from a lifetime of intense exposure, our
results demonstrate that adults become rapidly re-infected and parasitaemic following
an effective curative treatment.   Neither genetic resistance nor long-acquired immunity
appears to be sufficiently strong or widely present in this population to completely inhibit
parasitaemia and its symptoms.
Rapid re-infection and patency among treated malaria-immune adults was recognised
more than a decade ago in western Kenya (Hoffman et al.  1987).  This general
susceptibility and rapid appearance of low density blood stage infections may result
from the ineffectiveness of anti-sporozoite and anti-liver stage immunity or to an asexual
blood stage effect coupled with a pre-erythrocytic stage immunity that reduces but does
not completely eliminate all infected hepatocytes (Hoffman et al.  1987); (Hoffman,
1996).  
52
In spite of comparable malaria attack rates measured in adult males and females, the
relatively small size and ecological uniformity of the KND study area, and seasonal
climatic conditions that impinge evenly, thereby smoothing over ecological and
hydrological differences, our analysis identified a significant difference between
locations in the mean time to infection.   This difference may relate to the geographic
concentration of well-established irrigation systems in the western compounds.  If this
was not due to chance, it is likely that even more highly significant differences between
locations will exist in the KND during dry season conditions.  This observation may be
supported by location analysis of data from the wet and dry season infant cohorts.  Drug
and vaccine efficacy trials might be intentionally focused within particular areas of the
KND in order to achieve rapid endpoints and tight confidence intervals.  
Contrary to expectations, the ID of primary parasitaemia in this adult cohort was virtually
identical to that of a location-matched cohort of infants/young children, 6-24 months old,
who were curatively treated and followed through 20 weeks of the wet season the
following year [Adult ID 7.03 infections/person-year, vs. Infant/young children ID 7.06
infections/person-year; Relative Risk (95% CI) = 0.99 (0.82 - 1.19) (Baird, 2001).  The
cumulative incidence profiles of adult and infant cohorts indicate the same rapid rise
and plateau effect.  Among infants, the most rapid rise in incidence occurred between 5
and 10 weeks with a plateau reached at week 10 that incremented only slightly more by
the 20 week endpoint.  In an analogous manner, new infections among adults rose most
steeply from weeks 5 (Male CI = 0.22, Female CI = 0.21) to 10 (Male CI = 0.81; Female
CI = 0.77).  Among infants, only 18 new infections occurred in weeks 11 to 20, leaving
2.3% of the wet season cohort parasite-free.  In a similar manner, adult CI attained 0.88
in week 13 and only 18 additional subjects (9.5% of the infected cohort) developed
patent infections during the ensuing 7 weeks of study.  
We assumed that adult life-long residents of Navrongo, in contrast to their young
children, would manifest a lower or delayed incidence of patent re-infection, lighter
parasitaemia at the time of re-infection, and mild or negligible clinical manifestations. 
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We found lighter parasitaemia and decreased clinical manifestations in adults, but a
near identical rate of re-infection following radical cure.  A lower attack rate in adults
might have been observed had both cohorts been studied simultaneously, but was not
apparent in our comparison of wet season ID’s for adults during 1996 and for infants
during 1997.  Heightened transmission impacting upon adults, or reduced transmission
experienced by the infant cohort may have obscured real differences attributable to age
dependent immunity.  
Interestingly, in contrast to the near equal incidence density seen in adults and children,
we observed among adults that the > 40 years old age group had a lower ID of re-
infection as compared to those < 40 years old, suggesting an effective age-dependent,
naturally acquired immunity.   Under identical conditions of risk, an anti-parasite
immunity capable of barring certain genotypes and suppressing parasitaemia to sub-
clinical levels in adults would be expected to prevent or delay the patency of primary
infections relative to those sustained by infants.  
As expected, adults experienced parasite densities and febrile episodes that were
considerably reduced from those recorded in the infant cohorts (Scheller et al.  1995);
(Baird et al, 2001).  It was interesting to note that many of the infected Ghanaian adults
in the present study experienced episodes of illness that corresponded with, and may
have arisen from, their parasite infections.  We concede that the exclusive role of the
parasitaemia as a cause of their illness cannot be ascertained with certainty since these
same individuals reported signs and symptoms more often by these same individuals in
the absence of parasites.  However, the 37 occasions of illness that corresponded
precisely with the first appearance of parasites following radical cure are most probably
the true result of infection.  Literature on the subject of adult malaria implies that adults
with lifelong exposure to malaria do not become ill when they become re-infected with
malaria parasites (Wilson, 1950); (Smith et al.  1995).  Our data suggest that this may
not be the case when parasites have been completely cleared.  Interesting recent
consideration has been given to the impact of liver schizonticidal radical therapy upon
protective immunity (Smith et al.  1999a) and to the potential loss of premunition in
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clinically immune adults who have undergone such curative therapy to eliminate their
“benign” chronic malaria infections.
None of the adult patients became severely ill, but they reported physical complaints
that limited their capacity to function normally, prompting them to interrupt their usual
routine and seek medical care.  Most of the symptoms observed were rather non-
specific. There were however significant differences between parasitaemic and non-
parasitaemic patients that may not have been due entirely to chance.  Although we did
not undertake or power this investigation to test a specific hypothesis of adult clinical
predictors of parasitaemia, we found dizziness and myalgia to be the best multivariate
predictors of parasitaemia. This pattern was confirmed when multivariate interactions
between different symptoms and parasitaemia were investigated. Parasitaemia was
directly linked only to dizziness and myalgia, which in turn were likely to occur in
combination with chills or nausea.  This is in contrast to other studies that did not find
symptom reports useful in diagnosing clinical malaria (Trape, 1985).   Our preliminary
findings suggest that adults presenting with dizziness or myalgia in association with
chills and headache are likely to be parasitaemic. 
The incidence data herein reported for adult males and females provides the necessary
foundation for rational design of trials to evaluate drug or vaccine effects.  Although
African infants and pregnant women will certainly be the target population for
vaccination when an effective product becomes deliverable, adults and school children
will probably be the earliest recipients, in whom safety, tolerance and infection-blocking
qualities can be readily assessed.  In this regard, it was important to demonstrate near
universal susceptibility to re-infection and its rapid manifestation as patent parasitaemia
in adult Ghanaian males and females. Additionally important in planning such studies is
our documentation of radical cure compliance and dropout rates, the proportion of
radically-cured subjects who dropped out prior to yielding an endpoint, and the
frequency and nature of illness that developed coincident with re-infection.   Applying
our findings of an 80% attack rate within 12 weeks to a prospective12 week trial of a
drug/vaccine with predicted 75% protective efficacy (PE), and an 80% probability
55
(power) of having the lower 95% confidence limit for that PE >70%, we would require a
population of 1,004 adults.  With these variables kept the same, but with the lower 95%
confidence limit relaxed to >60% for the PE, we would need only to enrol 151 subjects.   
In conclusion, this study has shown that Ghanaian adults of the northern Kassena-
Nankana District experience a seasonal ID of infection by P. falciparum that was
comparable to that of infants living in the same communities.  Within the 20 week wet
season virtually all adults had manifested a patent primary infection and many reported
illness that coincided with parasitaemia.  Adults experienced predominantly low-density
infections, characterised by mild clinical illness.   Dizziness, myalgia, chills, fever, and
headache were the most commonly reported symptoms that prompted health clinic
visits seeking medical care.  This study provides the foundation for designing efficient,
practical clinical trials and preventive strategies against malaria in this holoendemic
region.
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5.1 Abstract
The incidence density of infection and disease caused by Plasmodium falciparum in
infants/young children aged 6 to 24 months living in the holoendemic Sahel of northern
Ghana was measured during the dry season of 1996 and wet season of 1997.  At the
beginning of each season a cohort composed of 259 and 277 randomly selected
children received supervised curative therapy with quinine and Fansidar, and
primaquine for those with normal glucose-6-phosphate dehydrogenase activity.  The 20
weeks of post-therapy follow-up consisted of 3 home visits weekly and examination of
Giemsa-stained blood films once every two weeks.  Blood films were also taken from
children brought to clinic with illness.  The incidence density of parasitaemia after
radical cure was 4.7 infections/person-year during the dry season and 7.1 during the
wet season [relative risk (95% confidence interval) = 1.51 (1.25, 1.81), p=0.00001].
Although the mean parasitaemia count at time of re-infection in the dry season
(3,310/l), roughly equalled that in the wet season (3,056/l; p=0.737), the risk ratio at
95% CI for parasitaemia >20,000/l during the wet season was [1.71 (1.2, 2.4);
p=0.0025].  The risk ratio at 95 CI for parasitaemia >20,000/l with fever during the wet
season was [2.45 (1.5,4.1); p=0.0002].  The risk ratio for anaemia (haemoglobin <8g/dl)
at first post-radical cure parasitaemia showed no difference between seasons [RR
(95%CI) = 1.0 (0.73, 1.4); p=0.9915].  We did not see seasonal differences in anaemia
known to exist in this region, probably because the longitudinal cohort design using first
parasitaemia as an end point prevented the subjects from developing the repeated or
chronic infections required for anaemia induction. These findings bear upon the design
of malaria drug and vaccine trials in holoendemic areas.
5.2 Introduction
The risk of infection by Plasmodium falciparum within endemic regions varies widely
across geographic and seasonal parameters.  If one gauges risk as the time to reach a
proportion of 1.0 (i.e., 100% of those at risk have been infected), holoendemic areas of
sub-Saharan Africa often yield estimates of just 8 to 12 weeks (Pull et al.  1974);
(McElroy et al.  1997); (Beier et al.  1994).  This reflects an incidence density of
approximately 5 infections/person-yr.  In contrast, the time to 100% risk in most of the
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endemic regions of the Amazon basin range between 5 and 10 years, or an incidence
density of approximately 0.1 infections/person-year (Pan American Health Organisation,
1997).  
Risk of infection has been linked to patterns of morbidity and mortality caused by P.
falciparum (Delacollette et al.  1993); (Snow et al.  1997); (Alles et al.  1998); (Gupta et
al.  1999); (Modiano et al.  1998).   Severe anaemia represents the primary cause of
malaria-related death where the highest risk of infection prevails, while death due to
cerebral malaria predominates in areas where infection risk is lower. Naturally acquired
immunity in older children and adults in holoendemic Africa effectively prevents either
outcome in those groups, but degree of exposure in infants and young children defines
risk of specific disease outcomes.  Protection from cerebral malaria requires the
relatively heavy, uninterrupted exposure such as occurs through the Sahel of sub-
Saharan Africa, but this carries risk of severe anaemia.    
The threshold of exposure for protection from cerebral malaria versus that for significant
risk of severe anaemia is not known.  The argument has been made that diminishing
risk of severe anaemia by reducing exposure to infection, e.g., with mosquito bed nets,
may increase susceptibility to cerebral malaria (Snow et al.  1997).  However, the basis
of that argument lies in empirical observations.  It remains possible that an exposure
level ideal for maintaining protection against cerebral malaria lies well below the
exposure of risk for severe anaemia.  This represents a critical question in the context of
control strategies intended to diminish disease and death caused by malaria, especially
in sub-Saharan Africa.  Few studies in the region have linked disease risks to
quantitatively measured incidence density of infection.  Thus it is difficult to begin to
assign optimal exposure thresholds, i.e., incidence densities that induce protective
immunity from cerebral malaria but below those leading to severe anaemia. 
We measured the incidence density of infection by P. falciparum in infants and young
children residing in holoendemic northern Ghana, where seasonal severe anaemia is
the major cause of malaria-related morbidity (Koram et al.  2000).  Incidence density
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was measured as the post-radical cure attack rate for P. falciparum parasitaemia.   This
work provides relatively precise measures of incidence that may be linked to
established patterns of disease risk in the region, i.e., high risk of severe anaemia
among infants and young children. These studies provide a foundation for planning
intervention trials in the region, and contribute to the process of assigning risk to defined
degrees of exposure to infection.
5.3 Materials and Methods
Study site: The Kassena-Nankana District in the Upper East Region of northern Ghana
in West Africa (Fig. 2.1) served as the study site.  Approximately 141,000 people reside
in this district of typical Guinea savannah with sharply distinct wet and dry seasons (Fig.
2. 2).  Most residents practice subsistence farming, predominantly raising livestock and
growing millet.  They live within traditional compounds of extended family groups.  An
on-going census of the population conducted by the Navrongo Health Research Centre
tracks births, deaths, migration, and other features on a quarterly basis (the Navrongo
Demographic Surveillance System, NDSS).  Malaria is holoendemic (Binka et al.  1994)
and is the most important cause of morbidity and mortality (Binka et al.  1995).  
Study Subjects: Two cohorts were recruited, one at the beginning of the dry season in
November 1996 and another at the beginning of the wet season in May 1997.  Infants/
young children between the ages of 6 months and 24 months were eligible for
participation.  They were selected for recruitment by stratification of the study site
followed by a randomised selection of 16 "index" clusters of family compounds among
the four geographic regions of the district recognised by the NDSS.  The number of
subjects recruited from each zone represented a sample weighted according to the
proportional contribution to the entire population of the district.
Meetings were held with tribal and family group leaders representing the selected
"index" compounds.  The rationale, methods, risks and benefits of the study were
explained and questions addressed.  The assent of these leaders represented a key
element of the process of informed consent within the cultural context of northern
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Ghana.   We nonetheless repeated the process with individual volunteers at enrolment
in accordance with U.S. Navy regulations concerning the use of human subjects of
medical research (SECNAVINST 3900.39B) and those of the Ministry of Health,
Republic of Ghana.  The verbal explanation and the written informed consent forms
were in the native languages of the subjects (Kassim or Nankam). 
Each "index" cluster had a target of 19 study subjects.  However, variability in the
number of eligible subjects per compound required a uniform strategy for reaching
beyond the randomly identified "index" cluster.  When the "index" compound failed to
yield the target of 19 eligible subjects, the closest compound to the east served as a
secondary target for recruitment.  If necessary, the process was repeated in adjacent
compounds to the north, west, and south, always in that order.  The population-
weighted random selection of "index" compounds among zones assured all eligible
children in the district had an equal probability of selection.
Mothers indicating a willingness to participate in the study were transported with eligible
children to an enrolment station.  During the two week enrolment phase of each cohort,
approximately 40 subjects were screened daily by the research team.  Children with
peripheral blood haemoglobin concentrations >6.0g/dl and free of disease requiring
hospitalisation were enrolled.  Among the 349 children screened at the beginning of the
dry season (end of wet season), 94 were excluded due to severe anaemia.  These
severely anaemic children were taken to the district hospital for treatment.  Among the
286 children screened at the beginning of the wet season, 275 were enrolled; only 4 of
11 exclusions had severe anaemia.  The report by Koram et al.  (2000) details the
marked differences in prevalence of severe anaemia between these two randomly
selected cohorts.  Table 5.1 lists the statistical summary of each cohort.  
Radical Cure: Radical cure started on the day following enrolment.  Subjects received
quinine sulphate (Cox Pharmaceuticals or Royce Laboratories; 10 mg/kg, 3 times daily
for 4d), followed by Fansidar (Hoffman La Roche Pharmaceuticals; 1/2 tablet for 5kg
to 10kg body weight, and 1 tablet for >10kg, single dose).  Subjects testing normal for
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Glucose-6-phosphate dehydrogenase (G-6-PD, assay by NADP+ spot test; Sigma
Chemical Co., St. Louis, MO) received 0.3mg of primaquine base per kg body weight
(primaquine phosphate, Sanofi Winthrop Pharmaceuticals, New York, NY) once a day
for 14 days.  A licensed pharmacist prepared all of these medications in flavoured
syrups. A trained field health worker employed by the research team used a syringe to
dispense volumes of medicated syrup prescribed by the team physician.  Only 6 of 536
subjects (1.1%) missed 2 or more of the 27 doses.  In the dry season cohort 18 of 259
subjects (6.9%) and in the wet season cohort 27 of 277 subjects (9.7%) tested positive
for G-6-PD deficiency and primaquine was withheld from their radical cure. 
Laboratory: We used the qualitative NADP+ spot test with modifications to the
procedure recommended by the manufacturer (Sigma Chemical Co.).  Batches of 30
specimens were tested using a single positive control spot (G-6-PD-deficient control
from Sigma Chemical Co.).  Prescribed mixtures of blood (10l), buffer, and G-6-PD
substrate were incubated at room temperature (approx. 30C) for 10 min, blotted onto
filter paper, air dried and read in a darkened room under ultraviolet light.  We did not
use a 37C water bath or readings at timed intervals as prescribed by the kit
manufacturer.  Subjects diagnosed as G-6-PD-deficient produced blots that failed to
fluoresce to the same extent as most other blots (i.e., the negative control), and to the
same extent as the known G-6-PD-deficient sample on the same blotter (the positive
control).
Haemoglobin levels were measured using the Haemocue (Lee Diagnostics Inc.)
system.  A micro-cuvette preloaded with stable reagents drew in approx. 10 microlitres
of blood from the site of puncture. It was immediately placed into a portable spectro-
photometric instrument.  Stable control cuvettes provided by the manufacturer
confirmed proper operation of the instrument.  Axillary temperatures were obtained
using digital thermometers placed under the arm.  
Thick and thin blood films were stained with Giemsa reagents in the usual manner and
were read by an experienced malaria microscopist on the day collected.  200 optical
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fields under 1000X oil immersion magnification were examined before a film was
recorded as negative.  Counts of parasites in the thick film were based on the number of
asexual trophozoites per 200 white blood cells (WBC).  This number was converted to
parasites per l whole blood using a conversion multiple of 40 (assumes 8,000
WBC/l).  
Follow up: A trained field health worker with at least a secondary school education was
assigned to each "index" compound for the 18 days of radical cure and the 20 week
follow-up.  The field worker visited each compound within his or her area 3 times per
week to query mothers/guardians of the health of their child.  Complaint of illness
prompted transport of the mother and child to the district hospital for examination by a
physician, including a blood film examination for plasmodia. Every 2 weeks a blood film
was collected whether or not the mother complained of illness in her child.  Children
with malaria were treated with Lariam mixed in syrup (mefloquine HCl; Hoffman La
Roche, 20mg base/kg body weight in a single dose). Whether administered after an
unscheduled visit to hospital or after a routine blood film examination, therapy with
mefloquine marked the endpoint of participation in this study.  The efficacy of
mefloquine for therapy in these cohorts was virtually complete (Baird et al., ASTMH
conference, 1997).
Clinical Analysis: Children presenting with signs of disease (fever, anaemia) and patent
parasitaemia were considered to be ill with malaria.  Although other diseases certainly
occur in the district, and we have not yet estimated the risk attributable to malaria
among febrile or anaemic children, malaria infection overwhelmingly dominates the
burden of disease in these communities.  An important exception to this rule is epidemic
meningococcal meningitis, which did not occur during these studies. Evidence of
disease reported by the mother, including fever, rigors, or vomiting, when coupled with
patent parasitaemia were attributed to malaria.  Although the lower limit for permissible
haemoglobin at enrolment was 6.0g/dl we used haemoglobin of <8.0g/dl to define
anaemia as a disease endpoint in the presence of parasitaemia.
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Epidemiological Analysis:
Incidence Density.  Incidence density estimates the force of infection, or new infections
per unit person-time.  The administration of radical cure allowed classification of post-
treatment parasitaemia as a new infection.  In the absence of cure, recrudescence and
relapse confounds the estimate.  We used the direct method to measure incidence
density; the number of post-treatment parasitaemia divided by the sum of person-time
at risk.  Subjects no longer contributed person-time to the denominator after becoming
parasitaemic or when lost to follow-up.  
The incidence density of other endpoints was measured.  Parasitaemia with fever
(axillary temperature  37.50C) or with anaemia (haemoglobin <8.0g/dl) at parasitaemia
densities of >5,000/l, >10,000/l, >20,000/l, and >50,000/l constituted these
endpoints. Subjects having parasitaemia without the specified outcome variable were
designated as dropouts in these estimates, i.e. contributing person-time to the
denominator up to the time of unqualified parasitaemia.  
We used incidence densities to calculate the risk of an outcome in one group relative to
the risk experienced by another group using SPSS (version 8.0, Chicago, IL).  A relative
risk of 1.0 reflected no difference in the risk to the two groups, and the distance from 1.0
(in either direction) represented the degree of difference between the rates.  We
calculated 95% confidence intervals around the relative risks as measure of the
precision of our estimates.  The significance of the difference between the rates was
determined using Fisher’s exact or a chi square test depending on number of events
within groups.  
Cumulative Incidence: Cumulative incidence expresses the risk of an outcome over a
defined period as a proportion.  The primary risk evaluated in this study was first
parasitaemia after radical cure.  We also calculated risk of high-density parasitaemia
(>20,000/l).  The first 10 days following radical cure were considered to be free of risk,
and were excluded from the denominator of the estimate of cumulative incidence.  The
life table method using weekly intervals estimated cumulative incidence.  When
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calculating the risk of developing a parasitaemia >20,000/l, subjects developing
parasitaemia <20,000/l were treated as withdrawals, i.e., contributing to the
denominator up to the interval in which they became parasitaemic (assuming a mid-
interval event for all subjects).  
5.4 Results
Radical Cure: The prevalence of parasitaemia at enrolment in the cohorts was 69% and
52% at the end of the wet and end of the dry seasons respectively, and this probably
accounted for much of the vomiting that occurred during radical cure. Repeated
vomiting (3 or more episodes) occurred in 4.7% and 3.6% of subjects taking quinine at
the beginning of the dry and wet seasons respectively (p>0.1).  After the single dose of
Fansidar, 0.8% and 6.2% of subjects reported vomiting in the dry and wet season
cohorts (p<0.001).  During the administration of primaquine at the start of the dry
season and wet season cohorts, 4.6% and 6.8% of subjects had repeated vomiting
(p>0.1).  Despite the risk of vomiting, 531 of 537 subjects (98.9%) beginning radical
cure completed the regimen, and 530 had negative blood films on day 15 of radical cure
(>99% efficacy). 
Point Measures: Enrolment: The two cohorts were virtually identical with respect to
composition by sex, age, weight, and frequency of G-6-PD deficiency (see Table 5.1).
The prevalence of parasitaemia at enrolment was significantly higher among the cohort
at the beginning of the dry season (end of wet season) than among the cohort at the
beginning of the wet season (end of dry season); 69% vs. 52%, P<0.0001.
Table 5.1. Comparison of dry and wet season cohorts at enrolment of infants and   
                  young children in the Kassena-Nankana District of northern Ghana.
Feature Dry Season Cohort Wet Season Cohort P value
Sample Size 259 277 ---
Male:Female 0.9923 1.022 0.865
Mean Age (months) 14.98 14.83 0.759
Mean Weight (kg) 7.97 7.80 0.211
%G-6-PD deficient 6.95 9.71 0.247
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Parasitaemia 69% 52% 0.001
However, there was no difference either overall or within specific age groups in
geometric mean parasite densities between wet and dry season cohorts at enrolment
(see Table 5.2A).
First Parasitaemia: The density of first parasitaemia after radical cure was also similar
among age groups between the wet and dry seasons (Table 5.2B).  Infants <12 months
old in the dry season cohort exhibited a mean parasite density after radical cure that
approached being significantly higher compared to those in the wet season cohort
(P=0.061, see Table 5.2B).  
The prevalence of fever with first parasitaemia was 31% in the dry season cohort and
34% in the wet season (relative risk = 0.91, 95%CI=0.69, 1.18, p=0.464).  Only children
aged 12 months to 18 months had a slightly higher risk of fever during the wet season
[relative risk (95%CI) =0.67 (0.42, 1.07), p=0.083].
Table 5.2. Age-specific geometric mean P. falciparum parasite densities (95% CI) in
infants and young children in the Kassena-Nankana District in northern Ghana.
A. Enrolment.
 Age Group (months)  Dry Season Cohort  Wet Season Cohort  P value
 <12  1515 (949-2418)  925 (528-1620)  0.194
 12 to 18  811 (470-1401)  1169 (645-2120)  0.376
 >18  1084 (696-1688)  1150 (706-1875)  0.860
 All ages  1112 (842-1470)  1099 (801-1507)  0.911
 
B. Post-Radical Cure.
Age Group (months) Dry Season Cohort Wet Season Cohort P value
<12 3796 (2161-6667) 1704     (970-2991) 0.061
12 to 18 2580 (1461-4555) 5131 (2629-10013) 0.127
>18 3564 (2111-6015) 3716   (2174-6353) 0.913
All ages 3310 (2409-4547) 3056   (2177-4290) 0.737
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Incidence Density: Figure 5.1 illustrates the incidence density of infection among "index"
compounds representing the sample evaluated in the wet and dry season cohorts.  
Figure 5.1.  Incidence density among index compounds representing the sample
population for the wet (solid bars) and dry (dashed bars) season cohorts. Variance from
the mean incidence density in the wet season (solid line) and dry season (dashed line)
among index compounds was not significant (p>0.10 and p>0.10) by the Mantel-Cox log
rank test.  
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The data do not include 21 subjects that could not be retrospectively assigned to an
index compound. Only 11 of 15 "index" compounds (A through K in Fig. 5.1) appear in
this analysis because proximate compounds were lumped together due to uncertainty
with original "index" assignment.  All 15 "index" compounds were represented among
the 11 clustered compounds illustrated in Figure 5.1.   "Index" compounds in the wet
season cohort had incidence density ranging from 6.42 to 10.4 per person-year (Mantel-
Cox log rank test, p>0.10).  "Index" compounds in the dry season cohort had incidence
density ranging from 1.12 to 7.29 per person-yr (p>0.10).  These data illustrate the
relatively uniform incidence of new infection among the randomly selected "index"
compounds in both the wet and dry season cohorts.  
Table 5.3. Incidence density of Plasmodium falciparum parasitaemia post-radical cure
in infants and small children in the Kassena-Nankana District of northern Ghana.
Dry Season    Wet SeasonEndpoint
N Incidence
Density*
N Incidence
Density*
RRº 95%CI† P value‡
Any parasitaemia
+/-fever, anaemia
$with fever
£with anaemia
200
62
73
4.71
1.46
1.72
254
87
63
7.11
2.43
1.76
1.51
1.66
1.02
1.25, 1.81
1.20, 2.31
0.73, 1.44
0.00001
0.00225
0.99147
Parasitaemia >5,000/l
+/-fever, anaemia
$with fever
£with anaemia
90
37
33
2.18
0.89
0.80
121
61
27
3.39
1.71
0.76
1.56
1.92
0.95
1.18, 2.04
1.27, 2.87
0.57, 1.58
0.00146
0.00221
0.89733
Parasitaemia >10,000/l
+/-fever, anaemia
$with fever
£with anaemia
78
33
30
1.89
0.80
0.73
103
55
25
2.88
1.54
0.70
1.53
1.93
0.96
1.14, 2.05
1.25, 2.97
0.57, 1.64
0.00458
0.00264
1.00000
Parasitaemia >20,000/l
+/-fever, anaemia
$with fever
£with anaemia
55
23
20
1.33
0.56
0.48
81
49
18
2.27
1.37
0.50
1.71
2.45
1.04
1.21, 2.40
1.50, 4.05
0.55, 1.97
0.00249
0.00022
1.00000
Parasitaemia >50,000/l
+/-fever, anaemia
$with fever
£with anaemia
18
10
7
0.44
0.24
0.17
53
37
10
1.48
1.04
0.28
3.36
4.33
1.65
2.00, 5.82
2.13, 8.61
0.63, 4.35
0.00000
0.00001
0.33789
*outcomes per person-yr;  RRº = Relative Risk = the ratio of wet season rates over dry season; 
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†The confidence intervals are Sato limits;  ‡The p-value is Fisher’s exact (2-tail) chi-square;  
$Fever = axillary temperature >37C; £Anaemia = haemoglobin <8g/dl
Table 5.3 lists the incidence densities of new infection in the wet and dry season
cohorts. The table stratifies incidence density according to parasite density and
accompanying illnesses, i.e., with fever or anaemia.
Incidence density of any parasitaemia in the wet season was significantly higher than in
the dry season; 7.11 vs. 4.71 infections/person-yr, [relative risk ((95%CI) =1.51 (1.25,
1.81), p=0.00001].
The relative risk was still higher when fever was included in the endpoint; 1.46 vs. 2.43
infections/person-yr, [relative risk (95%CI) =1.66 (1.20, 2.31), p=0.0023].  However, for
parasitaemia with anaemia, there was no difference in incidence density between wet
and dry season cohorts (relative risk = 1.02, p=0.9915).  
The pattern of significant differences in incidence density between any parasitaemia, or
those with fever but not anaemia in the wet and dry season cohorts, appeared at all
strata of parasite density (Table 5.3).  In general, the greater the parasite density, the
greater the relative risk for that outcome in the wet season cohort.  Compared to the dry
season, the risk of having a febrile parasitaemia of any density was 1.66 times higher
than that in the wet season.  Similarly, the risk of developing febrile parasitaemia of
>5,000/l, >10,000/l, >20,000/l, and >50,000/l during the wet season was 1.92,
1.93, 2.45, and 4.33 times that in the dry season.  The 95% confidence intervals for all
of these relative risks did not include 1.0, and the p-values were always <0.0025.  In
contrast, the relative risk of parasitaemia with anaemia never produced 95% confidence
intervals that excluded 1.0, and the p-values were never less than 0.33.  
Cumulative Incidence: Figure 5.2 illustrates the cumulative incidence of all parasitaemia
and parasitaemia >20.000/l in the two cohorts.  The cumulative incidence of
parasitaemia after radical cure increased more slowly during the first 3 weeks of risk in
the wet season cohort compared to the same period in the dry season cohort
(cumulative incidence of 0.19 vs. 0.04; p=0.0025). 
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Figure 5.2. Cumulative incidence of any parasitaemia by P. falciparum in infants and
young children during the wet (solid circles) and dry (hollow circles) seasons, along with
cumulative incidence of high density parasitaemia (>20,000/ul) in the wet (solid
triangles) and dry (hollow triangles) seasons in the Kassena-Nankana District, northern
Ghana.
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The 20wk cumulative incidence of parasitaemia in the dry season cohort reached a
plateau at 0.76 at the end of 12 weeks, leaving about one quarter of the cohort virtually
risk-free for the remaining 2 months of follow-up.  In contrast, the wet season cohort
reached a plateau cumulative incidence of 0.93 at the end of 10 weeks.  During the
remaining 10 weeks of presumably high risk, only an additional 3.5% of subjects
became infected. 
A total of 6 subjects remained free of infection throughout the study, and these
accounted for the 3.5% risk of not being infected.  The 20-week cumulative incidence of
infection by P. falciparum was 96.5%.  The risk of parasitaemia <20,000/ul peaked at
about 25% in both cohorts at about the same time, at the end of nine weeks.  
5.5 Discussion
Intense transmission of P. falciparum occurred from May to February in the Kassena-
Nankana District of northern Ghana.  The incidence density of infection decreased
moderately during the dry season that commenced in October.  Transmission abruptly
dropped to very low levels only during the last two to three months of the dry season
(Fig. 5.2).  No significant differences appeared among children of any age in the dry and
wet season cohorts with respect to geometric mean density of parasitaemia at either
enrolment or first parasitaemia (Table 5.2A and 5.2B).  Appreciable differences between
seasons appeared only when the data were stratified by parasite count and fever (Table
5.3).  The relative risk of parasitaemia with fever at any density, >5,000/l, >10,000/l,
>20,000/l, and >50,000/l for the wet season cohort relative to the dry season cohort
was 1.66, 1.92, 1.89, 2.45, and 4.33, respectively. Risk of parasitaemia with fever
increased in proportion to the density of parasitaemia during the wet season.  In both
cohorts the incidence density of these parasitaemia outcomes diminished sharply with
increasing counts.  The outcomes of greatest relative risk during the wet season
represented low frequency events, e.g., parasitaemia >50,000/l with fever was four
times more likely to occur during the wet season, but occurred less frequently than the
lower parasitaemia levels with fever (1.04 vs. 1.71 events per person-yr).  
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Despite the relatively subtle parasitological and clinical distinctions between the dry and
wet season cohorts, the statistical power of vaccine trials applying endpoints of high
parasitaemia and fever would be enhanced by execution framed to capture wet season
risks.   The example of risk of parasitaemia >50,000/ul with fever measured in these
studies best illustrates this point.  If one assumes a vaccine efficacy of 85%, and the
operational requirement to have an 80% probability of having a 95% confidence interval
that excludes 70% (i.e., the lower limit of acceptability for efficacy), then the dry season
incidence rate of 0.24 events per person year for this outcome demands a sample size
of 2055.  Applying the same parameters to the 1.04 events per person year incidence
rate in the wet season gives a sample size estimate of just 363 subjects.   Relatively
subtle distinctions in seasonal end point incidence densities may profoundly impact
sample size requirements in intervention trials.  
Anaemia is an important feature of morbidity caused by malaria in the Kassena-
Nankana District.  The infants and young children in these studies showed dramatic
distinctions with respect to the prevalence of severe anaemia as seen at enrolment at
the end of the dry and wet seasons (Koram et al.  2000). In effect, an epidemic of
severe malarial anaemia occurred in these children as the wet season progressed:
apparently starting at 1% in May and rising to 24% in October.  Given the fact that we
have now documented that intense transmission continues at least to February, the
prevalence of severe anaemia may even worsen relative to the 25% rate measured in
October.  The relatively brief respite in transmission between February and May
appeared sufficient to allow recovery of most severe anaemia to above the 6.0g/dl level.
The work reported here and by (Koram et al.  2000) demonstrates the need for
longitudinal studies of seasonal risk of severe anaemia in northern Ghana. 
The relatively low risk of anaemia among our subjects with first parasitaemia and the
absence of any differences between the dry and wet season risks of anaemia is a
product of the experimental design.  Chronic infection causes anaemia in malaria
(Koram et al.  2000); (Miller et al.  1994).  Measuring the incidence density of infection
necessitated radical cure and, thus, the interruption of chronic parasitaemia.  Moreover,
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we could not enrol the 25% of screened children with severe anaemia, so that children
in the dry and wet season cohorts began radical cure with similar anaemia profiles,
parasitological features, and chemotherapy.  Thus it was not surprising that the first
parasitaemia of the dry season had no less risk of anaemia compared to that in the wet
season.  This study has demonstrated that intervention trials applying an endpoint that
includes severe anaemia should allow for a chronic course of parasitaemia.  
The failure of 2.2% of subjects in the wet season cohort to develop parasitaemia
(accounting for a 3.5% residual risk) raises potentially important questions.  Given the
10-week plateau in the face of intense transmission, it is difficult to assign these residual
aparasitaemic subjects to chance.  These children were somehow protected.  Unknown
genetic factors may have precluded parasitaemia in these children, e.g. HLA or cytokine
promoter alleles (Hill, 1999); (McGuire et al.  1999).  However, in an adult cohort from
the same gene pools and treated and followed through the wet season in the same
manner (Owusu-Agyei et al., 2001), all developed parasitaemia.  Possible explanations
for the minority of child subjects failing to develop parasitaemia include consistently
applied and extraordinarily effective protective measures by the family (e.g., mosquito
netting, repellants, or antimalarials), and genetic or immunogenetic factors that protect
children but not adults from parasitaemia.  
The geometric mean parasitaemia densities at enrolment were significantly lower than
at first parasitaemia post-radical cure.  At enrolment, the dry and wet season cohorts
had geometric mean densities of 1112 and 1099/l, whereas these densities were 3310
3056/l at first parasitaemia (p<0.001 for each).  Many explanations for these
differences are possible, but we consider the effect of radical cure as most likely.
Although it is difficult to rule out drug-mediated interference with immune effectors that
limit parasite densities as an explanation, we instead favour diminished effectiveness of
premunition as a consequence of eradication of parasitaemia by radical curative
therapy.  Premunition is the protection from heavy parasite burdens imbued by lesser
parasite burdens.  We think the elimination of chronic, relatively low-grade parasitaemia
may have established susceptibility to acute, relatively high-grade parasitaemia.  This
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carries important implications with regard to experimental design in intervention studies
and to control strategies aimed at delivering effective therapies in holoendemic Africa.
Studies designed to address this important question should be carried out.  
In summary, these studies have documented intense malaria transmission with an
incidence density between 5 and 7 infections/person-yr through most of the year among
children aged 6 to 24 months living in the Kassena-Nankana District of northern Ghana.
A period of 2 to 3 months at the end of the dry season had very low risk of infection, and
marked a dramatic fall in the prevalence of severe anaemia.  Post-radical cure
infections carried risk of relatively high-density parasitaemia during dry or wet seasons.    
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6.1 Abstract
In malaria vaccine and drug trials, chemotherapy is often used to eliminate parasites in
the blood and liver prior to intervention so that time to infection can be studied. The
impact of such radical treatment on the incidence and severity of subsequent malaria
infections in semi-immune people is unclear.   In May 1996, a cohort of 197 volunteers
aged 18-55 years were randomly recruited for malaria incidence studies in the Kassena-
Nankana District of northern Ghana, radically cured, and their clinical status followed for
20 weeks through the peak malaria transmission season.  A further 202 adults were
sampled and followed up in the same way one year later without being treated.  Forty-
nine percent (49%) of volunteers in the treated group experienced clinical attacks
associated with parasitaemia in the follow-up compared with 38% in the untreated group
[log-rank test for equality of survivor functions X2=4.42; p= 0.035, RR (95% CI)=1.29
(1.03-1.61).  Clinical malaria in the treated group was associated with significantly more
symptoms, although the parasitaemia densities on presentation were lower. All cases in
the treated group were sensitive to Chloroquine compared with a 9% Chloroquine
failure rate at day 7 in the untreated group. Clinical malaria occurring after radical cure
may be distinctly different from "natural" disease and this may have significance for the
design and interpretation of intervention trials. 
6.2 Introduction:
The desire to avert 1-2 million deaths due to malaria of which over 90% occur in Africa,
south of the Sahara (Snow et al.  1999); (World Health Organisation, 1999) is
manifested in research to develop new anti-malarial drugs and malaria vaccines that
can be deployed in endemic sites (Miller et al.  1998). In intervention trials of malaria
vaccines and anti-malarial drugs, a common endpoint is incidence of parasitaemia
(symptomatic or asymptomatic) in the interval after the intervention is applied. Several
trials of insecticide treated mosquito nets (Stich et al.  1994); (Msuya et al.  1991) have
administered drugs to eliminate parasites prior to studying the effects of the nets. The
same is for testing of new anti-malarial drugs (Taylor et al.  1999) and vaccines (Alonso
et al.  1994) and is recommended for vaccine trials by the (World Health Organisation,
1997b). This facilitates subsequent study of the time to infection. There has, however,
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been little evaluation of the possible impact of radical therapy on the incidence and
severity of subsequent malaria episodes in semi-immune adults and children in endemic
countries. Does the elimination of parasitaemia render the host more susceptible to
disease caused by new inoculations? Can the 'cocktail' of drugs lead to important side
effects or immune suppression?  It is important to consider these questions from the
points of view both of the consequences for the volunteers and of the relevance of the
results of trials to situations where parasites are not cleared. 
The Kassena-Nankana District in northern Ghana, where malaria is holoendemic, is a
possible site for malaria vaccine trials.  To estimate malaria incidence a cohort of 197
adults between the ages of 18 to 55 years, was followed through the peak malaria
transmission period (May to October) of 1996 (Owusu-Agyei et al., 2001). A cohort of
children aged 6-24 months was also followed one year later, during the high
transmission period from May to October 1997 (Baird et al., 2001).  In both these
cohorts, a radical antimalarial therapy was administered to all volunteers to eliminate
malaria parasites in the blood stream and the liver so that the incidence of infection and
of clinical malaria could be studied.  During the 1997-study period, malaria-related
morbidity was also recorded in a further cohort of 202 adults who were not pre-treated.
We report here an analysis of the effects of radical therapy on incidence of clinical
episodes of malaria by comparing the patterns of malaria morbidity in the two adult
cohorts. 
6.3 Methodology:
Study site and population: The Kassena-Nankana district lies within the Guinea
Savannah woodlands between latitudes 100 30’ and 11000’ north of the equator and
between longitudes 1000’ and 1030’ west of the zero meridian, in the Upper East Region
of Ghana, bounded on the north by part of the international boundary between Ghana
and Burkina Faso. It has a population of 141,000 people as determined by a 90-day
cycle demographic surveillance [NDSS] (Binka et al., 1999).  Malariological surveys
over half a century have consistently reported that the area is holoendemic for P.
falciparum malaria (Coulbourne et al.  1955); (Binka et al.  1994)
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Subject Selection, Consent and Enrolment: The same sampling procedure, using the
Navrongo Demographic Surveillance System (NDSS) was used for both cohorts.
Sixteen (16) "index" compounds were randomly selected from 4 geographical zones of
the district with the number of compounds per zone proportional to the 18-55 year
population. Potential volunteers were then selected by visiting compounds radially in
concentric circles around each of the "indexed" compounds until a pre-determined
number of subjects (approximately 20) were recruited to form a cluster. Verbal informed
consent was sought with the chiefs, opinion leaders and the community members
(communal consent), prior to recruitment. 
In 1996, 202 adults were enrolled into the study following a screening process that
involved written and signed informed consent, taking of vital signs, clinical history,
physical examination by a physician, collection of blood for microscopy and G-6-PD
status, and urine from all the women for pregnancy tests. Those enrolled received
therapy designed to clear all malaria infections. All drugs were given under direct
observation at the homes of the volunteers by fieldworkers. The 18-day regimen
consisted of oral quinine sulphate (650 mg, three times daily for four days); followed by
doxycycline (100mg, twice daily for 10 days). Subjects testing normal for G-6-PD
(NADP + spot test, Sigma Chemical Co., St. Louis, MO) received in addition to quinine
sulphate and doxycycline, primaquine (0.5mg base per kilogram body weight once daily
for 14 days), given concurrently with the doxycycline. The success of the treatment was
confirmed by microscopic examination of a blood film collected on day 15.  All but five
subjects completed therapy, and were found to have cleared all parasites by
microscopy. 
The second cohort of adults was enrolled using the same procedures, with the
exceptions that G-6-PD status and pregnancy tests were not carried out as there was
no plan to treat this cohort. No treatment was given prior to follow-up.  
Follow-up: Fieldworkers paid thrice weekly visits to the volunteers at their homes to
inquire of their general health and to detect fever by measuring axillary temperature. 
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Blood films were collected every two weeks for the 20 weeks duration of the study, or if
the subject reported any signs of illness or had an axillary temperature  37.5 0C.  In the
latter case, an interview was conducted, information solicited on a detailed list of signs
and symptoms of malaria, and the subject was referred to a project physician in the
district hospital. 
Blood slides were prepared as Giemsa-stained thick and thin smears examined by 
1000X light microscopy using oil immersion. Parasitaemias were scored per microlitre of
blood by counting the number of asexual parasites per 200 white blood cells and
multiplying the parasite count by 40, assuming 8,000 white blood cells per microlitre. A
slide was considered negative if no parasites were observed within 200 high power
fields. A 10% random sample of all slides was re-examined for quality control. 
All symptomatic (any one or more of the following: reported/documented fever,
headache, chill, nausea, dizziness, myalgias) subjects with microscopy-confirmed
parasitaemia were classified as clinical malaria cases and promptly treated with
Chloroquine Diphosphate (25mg/kg body weight over 48 hours). Treatment was the
same for patients in the two cohorts; each sick patient seen by the study physician was
prescribed with 25mg/kg weight of Chloroquine, the standard practice in the ministry of
health of Ghana. The first dose of 600 mg was taken in the presence of the doctor’s
assistant and the remaining 6 tablets were (except in-patients admitted to the hospital)
packed for the patient to take home. , Patients were advised to take a further 600 mg (4
tablets the next day) and 300mg (2 tablets on the third day). Subjects with malaria
parasites in a blood smear collected routinely at one of the 2-week samples but who
had no clinical symptoms or signs of malaria were not treated.
Patients treated with Chloroquine were clinically evaluated again on days 2 and 7 after
initiation of therapy and blood films were taken at each of these visits. Those who did
not respond to the treatment were treated with three tablets of Fansidar® (Sulphadoxine
500 mg + Pyrimethamine 25 mg per tablet, Hoffman - La Roche), and followed up until
smear-negative.
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Data analysis: The primary outcome variable for the study was the time to the first
episode of clinical malaria. Owing to the pre-erythrocytic stage incubation period of the
parasite, the first ten days following curative therapy among the treated group were
excluded from analyses as risk-free period. Observation for clinical malaria among the
untreated cohort started from the day of recruitment; no days were excluded in the
analyses as risk-free period since they had no treatment prior to follow-up.
6.4 Results
The two cohorts had a similar age distribution (Table 6.1). Forty-four percent (44%) of
those who received radical therapies were female compared with 52% of the untreated
cohort (Table 6.1).
Table 6.1: Characteristics of adults in the two cohorts.
Radical Therapy group No Radical Therapy group.
Mean age (Range)   38.6 (18 – 55 years) 36. 8 (18 – 54 years)
Male 56% 48%
Parasitaemic at enrolment 56% 28%
Geometric Mean Parasite density 
at enrolment (95% CI)
116 (90, 150) 161 (114, 226)
Geometric Mean Parasite density
at First Malaria Clinical episode
201 (125, 325) 669 (516, 869) 
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Figure 6.1:Monthly Rainfall for 1996 and 1997 in the Kassena-Nankana district. 
The main difference at enrolment was that 56% of the volunteers who underwent a
radical therapy were parasitaemic by microscopy compared to only 28% among the
cohort that did not receive any radical therapy, due, presumably, to different levels of
transmission during the preceding dry season. Though the parasite densities at
enrolment were similar in the two cohorts. 
Environmental conditions relevant for malaria transmission were similar during the two
years. The rainfall from January 1996 to December 1997, recorded in the district
(Irrigation Company of Upper Regions, 2001) is shown in Figure 6.1. During 1996, the
total rainfall was 910 mm, quite similar to that of 1997 (861 mm) and also similar to the
mean rainfall for the previous 20 years (885 mm).  In both years, the rainy season
started in April and ended in October with similar monthly rainfall (Fig. 6.1).
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Figure 6.2: KM survival curve of clinical malaria development between the two cohorts
Clinical malaria attack rates in the 20 weeks follow-up on the two cohorts are presented
as Kaplan-Meier curves in Figures 6.2 and 6.3. In Figure 6.2, the curve for the radically
cured cohort falls below that for the untreated cohort, indication that the tendency is for
the former to have higher incidence of clinical episode.  Further evidence for the
protective property of individuals with parasitaemia is demonstrated in the curves in
Figure 6.3.  The average risk of developing clinical malaria is presented in Table 6.2.
Forty-nine percent (97/197) of volunteers in the treatment group developed clinical
malaria in the 20 weeks, compared with 38% (77/202) in the group that were not treated
prior to observation [log-rank test of equality of survivor functions, X2=4.42, p= 0.035;
RR (95% CI)=1.29 (1.03-1.61)].  This corresponded to a 22% increase in the risk of
developing a clinical episode of malaria in the treated cohort.  When we further
separated the untreated cohort into those who started with initial parasitaemia (56) and
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those who had no parasitaemia at enrolment (146), 33.9% (19/56) and 39.7% (58/146)
respectively had developed clinical malaria within the 20 week period (Log-rank test
X2=0.71, p= 0.4; RR (95% CI) = 1.17 (0.77–1.78). The curve for the untreated
individuals without parasitaemia at enrolment falls below that for the untreated cohort
with parasitaemia at enrolment, indication that the tendency is for those without
parasitaemia to have higher incidence of clinical episode.
Figure 6.3: KM survival curve among adults developing clinical malaria 
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Table 6.2A: Risk of developing clinical malaria in the treated and untreated cohorts
Cohort Proportion with Clinical Malaria          Statistic
Treated Adults         97/197
Untreated Adults       77/202
RR (95% CI) = 1.29 (1.03–1.61)
 2 = 4.42; p-value = 0.035
Table 6.2B: Risk of developing clinical malaria in the untreated cohort
Enrolment
Microscopy
Proportion with Clinical Malaria          Statistic
POSITIVE        58/146
NEGATIVE       19/56 RR (95% CI) = 1.17 (0.77–1.78) 2 = 0.71;  p-value = 0.4
Though the geometric mean parasite densities at enrolment were similar in both
cohorts, at first episode of clinical malaria, the geometric mean density was three times
as high in the untreated group as in the treated group (Table 6.1).  However,
substantially more symptoms were associated with each episode among the treated
group than the untreated (Table 6.3). 
Table 6.3: Comparison of symptom reports between the two adult cohorts
Symptom Histories Treated Not Treated Pearson 2 p-value
Documented Fever   10/97   1/77 5.88 0.01
Reported Fever within 48 hrs   82/97 42/77 18.85 0.00
Chill   76/97 30/77 27.81 0.00
Headache   83/97 55/77 5.20 0.02
Nausea   36/97 13/77 21.52 0.00
Myalgias   39/97 1/77 36.49 0.00
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All volunteers who received treatment prior to follow-up and were diagnosed with clinical
malaria during follow-up, cleared all parasitaemia by Day 7 when they were treated with
a full dose of Chloroquine. Nine percent (9%) of those who did not receive treatment at
enrolment failed to clear their malaria parasites by Day 7 when they were similarly
treated with full dose of Chloroquine. 
6.5 Discussion
While young children are highly susceptible to both malaria infection and disease, adults
who have lived in endemic areas and exposed to malaria transmission throughout their
lives, have a high level of immunity (Day et al.  1991) and rarely suffer from clinical
malaria (Trape et al.  1994).  We were therefore surprised when of 197 volunteers who
received treatment prior to being followed-up for incidence of malaria infection, 20% had
clinical attacks at first re-infection (Owusu-Agyei et al., 2001). Within the first 20 weeks
of follow-up, 49% of the subjects in this cohort had experienced a clinical malaria attack.
The disease rates were thus unexpectedly high for adults who have lived all their lives
in a holoendemic area (Trape et al.  1994). The significantly higher incidence of clinical
attacks among this treated cohort raise the question of whether clearance of malaria
parasitaemia can increase the risk of clinical attacks in adults when they subsequently
become re-infected. It has long been suggested that the presence of malaria parasites
may protect against superinfection (Sergent et al.  1935) or consequent clinical
episodes (Smith et al.  1999a); (Al Yaman et al.  1997).  Could radical therapy lead to
removal of this premunition?
The study of the initial cohort was not designed to investigate the effects of radical
therapy on semi-immune adults living in holoendemic malarious area.  The untreated
group was studied only because of the apparently unusual responses in the first year.
This imposes some limitations on the ways in which the findings can be interpreted, and
a properly randomised study with concurrent controls is needed to determine if these
are true effects or an artefact of having made the observations in two different time
periods. 
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However, the study design, selection of volunteers, treatment of subjects in the
treatment arm and follow-up in the two cohorts, observation techniques, data collection
and clinical monitoring of patients in the two cohorts were as near as possible identical.
Field data collection was carried out by the same field workers, slide reading by the
same technician and clinical diagnosis by the same physicians in the two cohorts.
We believe that the intensity of infection and mix of parasites circulating were similar in
the two years. The cumulative incidence curve for adults who were radically cured prior
to follow-up in the peak transmission season of 1996 was similar to that for the infants
who were radically cured and identically followed-up in the same period as the control
cohort (Fig. 6.4).  
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Figure 6.4: Cumulative Incidence of infection among adults and children
The rainfall patterns in the two years were also very similar (Fig. 6.1), although there
was a significant difference in the parasite prevalence rate (56% and 28%) in the two
cohorts at enrolment. The variation is within what has been reported previously in this
area (Owusu-Agyei, unpublished data). 
If pre-existing parasitaemia were protective against clinical malaria, then we would
expect those individuals lacking parasites at baseline to be more at risk than
parasitaemic individuals in the untreated cohort. The tendency, which we observed, was
in this direction though the effect was not statistically significant. It is possible that this
analysis was affected by misclassification of individuals with very low parasite densities
since parasite densities at baseline were very low. We may argue that the role and
significance of parasite retention may have been shown if we used PCR methods which
is more sensitive and would have detected sub-patent parasitaemia among a lot more
subjects who were classified negative by microscopy (Tirasophon et al.  1994).
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The most obvious sources of bias would act to decrease the relative risk of episodes in
the treated cohort.  Many of the clinical episodes may have been caused by other
pathogens but were classed as clinical malaria because of incidental parasitaemia
(Smith, 1996).  This could have happened in both cohorts, but we would expect less
over-diagnosis of clinical malaria in the treated than in the untreated group, since the
former were parasitaemic for much more of the time at risk.  Similarly, the fact that the
treated cohort became sick after less time at risk than the controls is remarkable since
parasites were present in the controls from the start of follow-up.  For these reasons it
could even be the case that the effect of radical therapy on disease incidence is
substantially greater than we estimated.
The fact that the density at first clinical malaria among the untreated group is much
higher than the enrolment density is an evidence that these are mainly malaria
episodes. The similarities between the densities at first clinical malaria and enrolment in
the treated cohort might be used to argue that these are not really malaria episodes.
However, since these episodes occurred disproportionately at the same time as
parasites re-appeared, we believe that the explanation for the low densities is more
likely to be that the treatment group became sick at lower parasite densities as a result
of a loss of parasite tolerance.
The responses to Chloroquine treatment are also of interest. Though completion of the
dose schedule was not directly observed, there was no reason to suspect a difference
in compliance between the cohorts.  The 9% parasitological failure rate is comparable
with other studies carried out in the sub-region (Afari et al.  1992). Untreated individuals
in holoendemic areas often harbour many clones of parasites (Ntoumi et al.  1995);
(Beck et al.  1997),(Rougemont et al.  1991) and so the chances of a Chloroquine
resistant strain being present is higher than the resistance rate for single infections. The
absence of resistance among the treated group is probably due to these patients being
re-infected with only one or a few strains of parasites. 
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Clinical malaria occurring after radical therapy may be distinctly different from the
“natural” disease, and the implications of treating asymptomatic individuals may be very
different in adults than for children.  Intermittent treatment in a highly exposed
population has been shown to be of benefit in the first year of life (Schellenberg et al.
2001).  As radical cure is a part of the standard strategy for evaluating malaria vaccines
8 these findings may have significance for the design and interpretation of such trials.
Clinical malaria as an outcome needs to be evaluated and such trials must provide
adequate facilities to treat patients who become ill.
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7.1 Abstract
Malaria and anaemia accounted for respectively 41% and 18% of hospital deaths in the
Kassena-Nankana district of northern Ghana during 1996.  We measured haemoglobin
(Hb), malaria prevalence, and anthropometric indices of 6-24 months old infants and
young children randomly selected from this community at the end of the high (May –
October, n = 347) and low (November – April, n = 286) malaria transmission seasons.
High transmission season is characterised by rainfall (800 – 900 mm/yr.); while the
remaining months receive less than 50 mm/yr.  Severe anaemia, defined as Hb <
6.0g/dL, was 22.1% at the end of the high transmission season compared to 1.4% at
the end of the low transmission season, [OR (95% CI) = 20.1 (7.1 – 55.3)].
Parasitaemia was 71% and 54.3% at these time points [OR (95% CI) = 2.1 (1.5 - 2.9)].
Nutritional anaemia appeared to have little impact upon this seasonal difference since
anthropometric indices were comparable.  Although the relative contributions of other
causes of severe anaemia were not assessed, repeated malaria infections may be a
primary determinant of severe anaemia among infants and young children during the
high transmission season. 
7.2 Introduction
Anaemia is one of the leading causes of childhood morbidity and mortality world-wide
(World Health Organisation, 1996c).  In malaria endemic areas, anaemia is among the
leading causes of morbidity and mortality in hospitalised patients.  It has been observed
that in malaria endemic areas, the incidence of severe anaemia and age specific rates
of anaemia are strongly correlated with the intensity of Plasmodium falciparum
transmission (Clark et al.  1949) and significant improvements in haematological indices
have been seen after malaria control trials (Alonso et al.  1991); (Greenwood et al.
1989).  While there may be several causes for the anaemia, P. falciparum infection is
believed to be a major contributory factor to the aetiology of severe anaemia seen in
malaria endemic areas.  This may be as a result of direct destruction of parasitised red
blood cells, through immune mechanisms that destroy both parasitised and non-
parasitised red cells, or suppression of the bone marrow as a result of the infection.
Kurtzhals and colleagues have recently reported that some of these mechanisms may
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operate in asymptomatic infections in Ghanaian school children (Kurtzhals et al.  1997).
We report here the prevalence of severe anaemia (haemoglobin concentration <
6.0g/dL) seen among infants and young children aged 6 to 24 months at the end of the
high and low malaria transmission seasons in the Kassena-Nankana District.  This
study was part of a larger study that investigated the incidence of new malaria infections
among the population, which will be reported separately. 
7.3 Methods
Study Area: The study was conducted in the Kassena-Nankana district in northern
Ghana, an area that has been demographically well characterised previously (Binka et
al.  1994). In summary, the district lies in the sub-Sahelian region of West Africa and is
bounded on the north by part of the international border between Ghana and Burkina
Faso. Annual rainfall averages approximately 850 mm almost all of which occurs in the
wet months of May – September, the rest of the year being dry.  One of the main
features of the area is a large reservoir in the centre of the district that provides water
for irrigation.  Malaria transmission occurs throughout the year although there is very
little transmission in the district towards the end of the dry season, except for
compounds sited near the few permanent bodies of water (Binka et al.  1994).
Study Population: The district population of approximately 141,000 has been followed
up regularly since 1993.  The children who participated in the present study were
randomly selected from enumeration clusters of the Navrongo Demographic
Surveillance System (NDSS).  Two cross sectional surveys were conducted at the end
of the low and high malaria transmission seasons to select children for a malaria
incidence study.  Infants/ children were eligible to enter the study if they were aged
between 6 and 24 months at the beginning of the study, were not suffering from any
acute or chronic illness at the time of enrolment, were going to reside in the area for the
following 6 months and their parent(s) or guardian(s) agreed to their participation in the
study.  These criteria were applied for entry into the malaria incidence study.
Investigation review boards at Naval Medical Research Centre, NAMRU #3 and the
Ministry of Health, Ghana approved the study protocol.
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At enrolment, all the children were weighed, examined physically for signs of illness,
and their axillary temperature taken.  A blood smear was made for the identification and
quantification of malaria parasites and haemoglobin estimated using a Hemocue®
photometer (Leo Diagnostics, Sweden).  They were also screened for the presence of
G-6-PD deficiency using a qualitative visual fluorescence method for the presence of
G-6-PD in whole blood (Sigma Diagnostics, USA).  The test is used to distinguish
normal from grossly deficient samples.  Haemoglobin genotype was determined by gel
electrophoresis of a filter paper blot at NMIMR.  All children who qualified whose
parents gave informed consent to take part in the study were then enrolled.  Children
with haemoglobin concentration less than 6g/dL were excluded from the associated
malaria incidence study but are included in this report.  All blood slides were stained
with Giemsa stain and examined under oil immersion with a light microscope (ocular
magnification 10X and objective 100X).  All microscopic examinations were done the
same day by the study microscopist.  Parasite densities were estimated by determining
the number of parasites per 200 white blood cells and multiplying by 40.  A slide was
declared negative after examination of 200 high power fields. 
Data analysis: Differences between the two child cohorts (high and low transmission
seasons) with respect to malariometric indices were tested using 2  for proportions and
Student’s t-distribution for means.  Parasite counts were log transformed [log(x+1)] and
densities reported as geometric mean densities [antilog of log(x+1)/n) where x is the
parasite count per l of blood and n is the total number of children with parasitaemia].
Statistical significance is reported at p < 0.05.  
7.4 Results
A total of 347 children were screened at the end of the high transmission season in
November, 1996 and 286 children were screened at the end of the low transmission
season in May 1997.  The two child cohorts were comparable in terms of age, sex and
anthropometric characteristics (Table 7.1).  This was expected as each child cohort was
selected randomly from the database of the Navrongo Demographic Surveillance
System (NDSS).  The prevalence of Glucose 6 Phosphate Dehydrogenase (G-6-PD)
96
deficiency and haemoglobinopathies were also similar in the two groups of children and
no episode of hemolysis was observed following administration of primaquine for radical
cure.
Table 7.1.  General characteristics of study children
First child cohort (end of high
transmission Season); n = 347
2nd child cohort (End of low
transm. Season); n = 286
Mean age months (95% CI) 15.0 (14.4, 15.6) 14.8 (14.1, 15.4)
Sex
Males
Females
51.9%
48.1%
50.2%
49.8%
Mean WFA-z-Score (95% CI) -2.20  (-2.3140, -2.0264) -2.19 (-2.3471, -2.0366)
% with G-6-PD deficiency 7.1% 10.05%
Hb phenotype (%)
A
AS/AC
SS/SC/CC
66.2%
29.7%
4.1%
69.6%
26.9%
3.5%
Table 7.2 shows the results of univariate analysis comparing children seen at the end of
the high transmission season with those seen at the end of the low transmission
season.  An arbitrary haemoglobin concentration of 6.0g/dL was used to define eligibility
into the malaria incidence study on the grounds of anaemia.  Based on this criterion,
more than one out of every 5 children (22.1%) screened at the end of the high
transmission season was found to be ineligible. 
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Table 7.2.  Comparison of the cohorts seen at the end of the high and low 
transmission seasons in the Kassena-Nankana District.
Characteristic
First child cohort.
(end of high
transmission
season)(N = 347)
Second child
cohort. (end of low
transmission
season). (N = 286)
OR (95% CI)
P value
Parasite rate 70.0% 54.3% 2.1 (1.5, 2.9)
0.001
Parasite Densitya 1074 (40 - 103,990) 1118 (40 - 39,520) __ NS b
Proportion with 
Hb. < 6.0g/dL
22.1% 1.4% 20.1 (7.1, 55.3) 0.0001
Mean Hb. g/dL
(95% CI) 
7.2 (7.0, 7.4) 8.9 (8.7, 9.1) __
0.0000
1 b
Proportion of children
with Hb. < 6.0g/dL and
parasitaemia
81.8% (n = 66) 100% (n = 4) 0 (0, 8.11) NS c
Proportion of children
with Hb.  6.0g/dL and
parasitaemia
67.9% (n = 259) 53.6% (n = 278)
1.84
 (1.27, 2.65) 0.001
Proportion of children
with fever
10.8% 3.3% 3.56 
(1.69, 7.52)
0.0001
Proportion of febrile
children with severe
anaemia(Hb<6.0g/dL)
43.2% (n = 37) 0% (n = 9) __ 0.02 c
Proportion of febrile
children with
parasitaemia
71.4% (n = 37) 77.8% (n = 9) __ NS
OR = odds ratio; CI = confidence interval; Hb = haemoglobin; aGeometric Mean Parasite Density (range);
bStudent’s t-test; cFisher’s exact test; NS = Not significant at P < 0.05
This figure was significantly lower at the end of the low transmission season (1.4%);
[OR (95% CI) = 20.1 (7.1, 55.3); p < 0.0001].  At the end of the high transmission
season, the mean haemoglobin concentration was 7.2 g/dL (7.0, 7.4) compared to 8.9
(8.7, 9.1) at the end of the low transmission season (p < 0.0001).  Figure 7.1 shows the
distribution of haemoglobin values seen among the two child cohorts.  Almost all
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haemoglobin values below 6 g/dL were seen at the end of the high transmission season
while haemoglobin values above 12 g/dL were mainly seen among children at the end
of the low transmission season.
Figure 7.1: Scattergram showing the distribution of haemoglobin values by age (6-24
months) seen among the two cohorts, the first child cohort seen at the end of the high
transmission season () and the second child cohort () seen at the end of the low
transmission.  Many more children seen at the end of the high transmission season had
haemoglobin values below 6 g/dL while all of those with Hb > 12 g/dL were seen after
the low transmission season.
The prevalence of fever (axillary temperature  37.5o C) was significantly higher (10.8%)
at the end of the high transmission season (range, 37.5 o C – 39.7 o C; mean 38.1 o C)
than at the end of the low transmission season (3.3%) [OR (95% CI) = 3.56 (1.69, 7.52),
p < 0.001]; (range, 37.5 o C – 39.2 o C, mean 37.9 o C).  Forty three percent (16/37) of
febrile children seen at the end of the high transmission season were also severely
Scatter plot of Hb values among the two child cohorts
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anaemic while none of the nine febrile children at the end of the low transmission
season were anaemic.  The mean Hb of febrile children at the end of the high
transmission season was 6.3 (5.7, 7.0) g/dL compared to 8.3 (7.2, 9.4) g/dL for febrile
children seen at the end of the low transmission season [p = 0.005].  Indeed, even for
afebrile children the mean haemoglobin level was significantly lower at the end of the
high transmission season [mean Hb = 7.3 (7.1, 7.5)] than that at the end of the low
transmission season [mean Hb = 8.9 (8.7, 9.1), p < 0.001].  At the end of the high
transmission season the mean (Hb) was lower in those with fever than those without
fever [6.3 (5.7, 7.0) g/dL vs. 7.3 (7.1, 7.5), p = 0.002.  This difference was not found at
the end of the low transmission season.
Infants/ young children seen at the end of the high transmission season were more
likely to have P. falciparum infection (70.1%) than children seen at the end of the low
transmission season (54.3%); [OR (95% CI) = 2.1 (1.5, 2.9), p < 0.001].  Infections were
almost entirely due to P. falciparum, which accounted for more than 98% of infections
seen.  Other infections were due to P. malariae and P. ovale.  The geometric mean
parasite densities were similar at the end of both transmission seasons [high
transmission season, mean = 1111, range (40 – 103,900) and low transmission season,
mean = 1118, range (40 – 39,520)].  However, heavy infections (parasite densities 
20,000 /l) were more prevalent at the end of the high transmission season (5.1%)
compared to the low transmission season (2.6%) but this difference was not statistically
significant [OR (95% CI) = 2.01 (0.59, 8.72)].  Febrile children tended to have higher
parasite densities than afebrile children.  At the end of the high transmission season the
geometric mean parasite densities among febrile and afebrile children were 1879 (857,
4124) and 1026 (795, 1326) respectively, (p = 0.13).  The respective mean values seen
at the end of the low transmission season were 2631 (290, 23,845) and 996 (720,
1377), (p = 0.20).  
The prevalence of anaemia was also analysed with respect to parasite densities.  At
similar intensities of parasitaemia children seen at the end of the high transmission
season were more likely to have lower Hb than children seen at the end of the low
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transmission season (Fig. 7.2).  The differences in the mean Hb concentrations were
significantly different at the lower parasite densities but not at the higher parasite
densities.  However, Hb concentration was still considerably less in children seen at the
end of the high transmission season even at the higher parasite densities.
Figure 7.2: Chart showing the mean haemoglobin levels and average parasite density
among children seen at the end of the high transmission season (dark bars) and at the
end of the low transmission season (lighter bars).  In all categories of parasite densities,
mean haemoglobin values were higher at the end of the low transmission season
compared to the high transmission season.  Error bars are standard errors of the mean.
7.5 Discussion
The primary objective of the main study was to determine the incidence of P. falciparum
infections in infants/ young children aged 6-24 months in the Kassena-Nankana District.
In this paper we have reported data acquired at the time of enrolment into the
longitudinal study.  A very high prevalence of anaemia was observed at the end of the
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wet season, corresponding to the high malaria transmission season in the district (Binka
et al.  1994).  Among this randomly selected cohort of children, the prevalence of
anaemia (haemoglobin < 6.0g/dL) was 22.1% at the end of the high malaria
transmission season compared to 1.4% among children seen at the end of the low
transmission season.  The prevalence of parasitaemia was 70% at the end of the high
transmission season and 54.3% at the end of the low transmission season.  However,
there was no difference between the intensity of infection as measured by geometric
mean parasitaemia in those with parasites seen at the end of both transmission
seasons.  There was also no seasonal variation in nutritional status as measured by
anthropometric indices.  Febrile episodes were more common at the end of the high
transmission season and a higher proportion of febrile children had coincident
parasitaemia.
Anaemia in children is a commonly reported problem from hospitals and clinics in
malaria endemic countries.  In the Kassena-Nankana District it accounted for
approximately 20% of all admissions in the year preceding the commencement of this
study.  In a recent study in the same area (Binka et al.  1994), Binka and colleagues
reported significant malaria morbidity among infants/ young children of 6–24 months of
age. In that study the authors reported that children in this age group suffer most from
the effects of P. falciparum infection, although parasite rates in this population peak at a
later age.  Young children aged 6-24 months had the lowest mean haemoglobin levels,
the highest geometric mean parasite densities and the highest prevalence of fever
coincident with P. falciparum infection. 
Infection with P. falciparum is known to be one of the major causes of childhood
anaemia in malaria endemic areas.  In epidemiological studies a strong correlation has
been reported between the incidence of severe anaemia, age specific rates of anaemia
and the intensity of P. falciparum transmission and also malaria control trials have
usually been followed by marked improvements in haematological indices in children
(Alonso et al.  1991); (Greenwood et al.  1989); (Molyneux et al.  1980).  Malaria
transmission in this area is intense and seasonal with most of the infections occurring
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during the rainy season.  In the main study, the malaria attack rate was 8 infections per
child per year during the rainy season compared to 5.2 per child per year during the dry
season.  And during the dry season almost all infections occurred during the first part of
the season (attack rate = 5.1 per child per year) compared to the latter part when the
attack rate was only 0.9 infections per child per year (Baird et al, 2001).  Children were
therefore very likely to have suffered from repeated attacks of malaria during this period.
If the attacks were frequent such that there was not enough time for complete recovery
from one infection, a marked drop in haemoglobin levels would have resulted by the end
of the transmission season.
The mean haemoglobin level at the end of the high transmission season was
significantly lower than that reported in the same age group of children from the
previous study by (Binka et al.  1994).  With the spread of Chloroquine resistance in
sub-Saharan Africa it is likely that the efficacy of Chloroquine treatment will be reduced
considerably in most areas resulting in poor haematological recovery, especially in
children in areas of intense malaria transmission.  Such a situation has been reported
from sites in East Africa, where there is high prevalence of Chloroquine resistant P.
falciparum (Bloland et al.  1993), and recently in Cote d’Ivoire with only moderate level
of Chloroquine resistant P. falciparum (Henry et al.  1996). In a recent study of the
situation in the country, only 60% of infections in the northern part of the country were
found to be sensitive to Chloroquine treatment with the prevalence of RI responses as
high as 31% (Koram, unpublished data).  Thus, the frequent infections during the high
transmission season coupled with a probable reduction in the efficacy of Chloroquine
treatment, the drug of choice in the area, are likely to have contributed to the 22%
prevalence of severe anaemia seen at the end of the high transmission season.
In this study, the parasite densities were similar at the end of both transmission
seasons.  The degree of anaemia associated with P. falciparum infection has not
always been proportional to the severity of parasitaemia seen and anaemia has often
been reported to be found at times when the parasitaemia has waned (Jilly & Nkrumah,.
1964); (Nkrumah, 1973).  This could be due to the fact that, most of the reported studies
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determined the level of anaemia and the intensity of infection at the same time.
Presumably, the level of anaemia is a cumulative effect of several episodes of infection
and the intensity of infection determined at the same time as the haemoglobin
concentration is not a good indicator of the haemoglobin concentration.  The report
presented here is also the results of two cross sectional studies and would have
suffered from the same deficiencies.  However, in our larger incidence study, the
frequency of infections was significantly higher in the wet season than in the dry season
(Baird et al., 2001).
Malarial anaemia has been postulated to be secondary to direct destruction of both
infected and non-infected rbc’s and also to suppression of bone marrow function as a
result of the infection (Kurtzhals et al.  1997); (Topley, 1968) in The Gambia showed
that the seasonal fall in haemoglobin values in adults could be prevented if malaria
parasitaemia was cleared or reduced by administration of Sulphadoxine-
Pyerimethamine prophylaxis. The relatively high prevalence of anaemia observed at the
end of the high transmission season opens up the possibility of using incidence of
anaemia as a primary outcome variable for the effects of novel intervention tools such
as vaccines, at least in areas of high malaria transmission. 
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8.1. Abstract
We sought to elucidate factors associated with severe anaemia in young Ghanaian
children, 6-24 months old, by analysing two studies separated by 4 years, but
conducted in the same community and at the same seasonal time point.  Age-adjusted
comparison confirmed that the proportion of severely anaemic children and overall
mean Haemoglobin (Hb) levels, in the 2000 sample were significantly improved over
those of the 1996 (17.5 % vs. 26.4%, P = 0.03; Hb 7.5 g/dL vs. 6.9 g/dL, P = 0.002).
Weight for age z-scores also indicated a significant improvement in the 2000 sample (-
1.93 vs. –2.20, P < 0.05).  Independently, each survey identified statistically significant
associations between severe anaemia and age, parasite rate, fever, and sex.  Relative
to children with Hb  6.0 g/dL, those with severe anaemia (Hb < 6.0 g/dL) were older,
more frequently parasitaemic [OR (95% CI) = 1.60: (1.08-2.35)], more often febrile
[OR: (95% CI) = 2.44 (1.71-3.48)], and predominantly male [OR (95% CI) = 1.50 (1.05-
2.13)]. Evidence suggests that dramatic peaks and troughs of severe anaemia are
regular and possibly predictable events that may be used to gauge the health and
survival of young children in this area. 
8.2. Introduction
Severe anaemia may be the principal underlying cause of malaria death in areas of
intense seasonal malaria transmission such as the holoendemic Kassena-Nankana
District (KND) of northern Ghana (Binka et al.  1994; Koram et al.  2000).  A recent
malaria/anaemia study of young children 6 to 24 months old in this community revealed
that 22% of those sampled at the end of the wet season (November, 1996), a time
corresponding to agricultural and nutritional abundance, had haemoglobin (Hb)
concentrations below 6.0 g/dL.  In contrast, survey of the same age cohort six months
later, at the end of the dry season, and at a time of food scarcity found that only 1% of
the children fell into this category of severe anaemia (Koram et al.  2000).  With
entomological inoculation rates in non-irrigated and irrigated sectors calculated to be,
respectively, 72 and 800 infective bites per person-year (Binka et al., 1997), and a clear
pattern of malaria deaths that mirrored rainfall (Binka et al.  1994) , it was reasoned that
anaemia trends in this vulnerable age group were primarily influenced by the intensity of
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malaria transmission and that dramatic troughs and peaks of severe anaemia are
regular seasonal events.   If this is the case, then proportions of young children with
severe anaemia, rather than proportions dying, might serve as a more conservative and
accessible measure of malaria vaccine effect.  Towards this objective we sought to
elucidate factors associated with or influencing severe anaemia in young children of this
district by re-examining the previously collected data and by expanding the database
with newly acquired results.  We hypothesised that a repeat malaria-anaemia study of
the same age groups and locations as previously studied, but at a time corresponding to
the end of the 2000 wet season, would again show large numbers of young children
with severe anaemia.   Relative to the cohort with non-critical Hb, we also hypothesised
that severe anaemia would be associated with parasitaemia, higher parasite density,
more febrile illness, and residence proximal to perennial breeding sites of anopheline
mosquitoes.  Owing to natural decline by six months of maternally transferred protection
(Akanmori et al.  1995), and the greater vulnerability to infection than malnutrition, low
birth weight, and stunting conceivably impart, we further expected that severe anaemia
might be more prevalent among older children in the 6-24 month range studied, and
would be associated with higher rates of parasitaemia, greater parasite densities and
more febrile illness. 
8.3. Materials and Methods
Subjects and informed consent process.  The study site and population has been
described in published reports (Ghana VAST Study Team, 1993); (Binka et al.  1994).
As with previous studies, use was made of the Navrongo Demographic Surveillance
System (NDSS) a continually updated database that records virtually all births, deaths,
and movements in the district’s population of 141,000.  An accurate name, age, and
home location listing was made from this database of young children 6-24 months old
on the first of November, 1996, and again in November, 2000.  Respective parents and
community leaders were identified, contacted, and given a detailed explanation of the
study plan.  Informed parents wishing to have their children tested for malaria and Hb
gave their assent in writing or thumb print and brought their infants to a central location
for registration and testing. This research was approved by the scientific and ethical
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review boards of the Ghanaian Ministry of Health and the US Navy and was conducted
in accordance with regulations governing the protection of human subjects in medical
research.
Sample collection and screening.  Children were assigned a study number based upon
their consecutive order of appearance and given a brief physical examination.  Axillary
temperature was recorded and temperatures  37.5 were designated febrile.  A sterile
lancet was used to prick the heel or toe sufficient to make thick and thin blood films on a
Snow clean-labelled slide.  Approximately 5-µL additional blood was obtained for
haemoglobin determination by means of the Haemocue photometer (Leo Diagnostics,
Sweden).  Haemoglobin readouts were transcribed into the child’s record.  Parents were
informed when their child’s Hb readout was below 6.0 g/dL and treatment was initiated.
Based upon physical condition and Hb level, children were either administered daily
treatment with oral ferrous sulphate solution or typed in preparation for transfusion by a
malaria-free family member.  Oral Chloroquine (25 mg/kg) was provided for all
presumed cases of clinical malaria.  Malaria slides were stained with Giemsa and
examined under high power 100x oil immersion microscopy for the presence of malaria
parasites.  Parasite species were identified by morphology and parasite density per
microlitre of blood was estimated from counts per 200 white blood cells and an
assumption of 8000 lymphocytes/L.  Two hundred thick film fields were examined
before assigning a negative malaria diagnosis. 
Blood transfusion records.  Daily record of blood transfusions performed in the single
district hospital during the 18 month period of October 1999 to March 2001 were
evaluated as a complementary "index" of severe anaemia in the district population.
This activity recorded each recipient’s name, address, age, sex, blood type, malaria
status, and Hb level, as well as the identity and results of laboratory screening
performed on donors.  
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8.4. Results
Full data set comparisons between times and cohorts.  Severe anaemia was
significantly more prevalent at the time of the 1996 survey than in 2000 (22% vs. 12.5%;
p < 0.0002) (Table 8.1).   The ages of children in both the Hb < 6.0 and Hb  6.0 cohorts
of the 1996 survey were significantly greater than those of their respective 2000 cohorts
(P < 0.0001), and mean Hb levels in these two 1996 cohorts, were significantly lower (P
= 0.005) than their 2000 counterparts.  
Table 8.1: Characteristics of severe anaemia (Hb < 6.0) and non-critical anaemia (Hb
6.0) among two populations of Ghanaian children, 6-24 months old, surveyed in
November 1996 November 2000.
November 1996 November 2000
Characteristic Hb < 6.0 g/dL Hb  6.0 g/dL Hb < 6.0 g/dL Hb  6.0 g/dL
Number (%)
- Males 
- Females 
75 (22.0)
45 (25.4)
30 (18.3)
266
132
134
87 (12.5)
51 (14.6)
36 (10.4)
608
299
309
Mn. Age (mos.) ± 95% CI
- Males
- Females
16.0 ± 1.9
16.4 ± 1.5
15.4 ± 0.4
15.0 ± 0.7
15.3 ± 0.2
14.6 ± 0.9
12.8 ± 0.7
12.5 ± 1.0
13.8 ± 1.2
12.0 ± 0.3
12.1 ± 0.5
11.8 ± 0.5
Mn. Hb (g/dL) ± 95% CI
- Males
- Females
4.8 ± 0.2
4.9 ± 0.3
4.8 ± 0.2
7.8 ± 0.2
7.8 ± 0.2
7.9 ± 0.2
5.2 ± 0.1
5.3 ± 0.2
5.1 ± 0.2
8.2 ± 0.1
8.1 ± 0.1
8.3 ± 0.1
No parasitaemic (%)
- Males
- Females
55 (76.0)
32/45 (71.1)
23/30 (83.3)
181 (68.0)
90/132 (68.2)
91/134 (67.9)
49 (65.3)
30/47 (63.8)
19/28 (67.8)
296 (55.9)
141/256 (55.1)
155/273 (56.8)
GMPD/uL (95% CI)
- Males
- Females
1288 (860 – 1928)
1248 (737 – 2115)
1345 (709 – 2551)
1106 (842 – 1452)
904 (614 – 1330)
1349 (920 – 1977)
1644 (1062 – 2547)
2203 (1202 – 4036)
1037 (601 – 1791)
1312 (1066 – 1614)
1306 (955 – 1977)
1315 (984 – 1758)
Febrile (%)
Febrile-parasitaemic (%)
- Males
- Females
16/76 (21.0)
12/55 (21.8)
7/32 (21.9)
5/23 (21.7)
22/265 (8.3)
15/181 (8.3)
7/90 (7.8)
8/91 (8.8)
18/74 (24.3)
12/48 (25.0)
7/30 (23.3)
5/18 (27.8)
62/528 (11.7)
39/295 (13.2)
20/141 (14.2)
19/154 (12.3)
Mn. Weight (kg) ± 95% CI
- Males
- Females
7.9 ± 0.3
8.2 ± 0.5
7.4 ± 0.4
8.0 ± 0.2
8.3 ± 0.3
7.6 ± 0.3
7.7 ± 0.3
8.1 ± 0.4
7.1 ± 0.4
7.6 ± 0.1
7.9 ± 0.1
7.3 ± 0.1
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Moreover, significantly greater numbers of children, overall (69.2% vs. 57.1%, P <
0.001), as well as in the two Hb cohorts, were parasitaemic in the 1996 survey.
Analysis of each sample population subdivided into severely anaemic (Hb < 6.0 g/dL),
moderately anaemic (Hb 6.0-7.9 g/dL), and normal (Hb  8.0 g/dL) groups, revealed
that severely anaemic children in both surveys were older (1996: 16.0 months. Vs 14.3
months, P = 0.03; 2000: 12.6 months vs. 11.4 months, P = 0.02) and contained fewer
females than normal Hb groups (1996: 39.5% vs. 53%, P = 0.0002; 2000: 38.7% vs.
54%, P = 0.01). Relative to the normal Hb group, point prevalence of parasitaemia was
significantly higher in both the moderately (P < 0.001) and severely anaemic (P = 0.05)
children.
Age-stratified analysis.  Figure 8.1, which plots the frequency distribution of ages
sampled and proportions of severely anaemic children by age, shows uniformity in
sampling over age groups in 1996, and no indication of declining rates of severe
anaemia in the 18-24 month age range.   
The 2000 survey, by contrast, sampled preferentially in the 6-11 month range.  Children
of 20-24 months, who comprised 27% of the 1996 sample and 29% of its severely
anaemic cohort, comprised only 3% of the 2000 survey.  To determine whether this bias
may have been responsible for differences in prevalence of Hb between the 1996 and
2000 surveys, analysis was reapplied, but only to children 12-18 months of age in the
two survey populations.  This age-adjusted comparison confirmed that the proportion of
severely anaemic children and overall mean Hb levels, in the 1996 sample were
significantly different from those of the 2000 sample (26.4% vs. 17.5%, P = 0.03; 6.9
g/dL vs. 7.5 g/dL, P = 0.002).  Differences between survey times for rates of
parasitaemia in children 12-18 months old (69.2 % vs. 57.1%) and the GM parasitaemia
of those with patent infections were not statistically significant.
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A
B
Figure 8.1.  Comparative frequency distributions of ages sampled and the proportions
of severely anaemic (Hb < 6.0 g/dL) children detected by age group in two community-
wide surveys of malaria-anaemia, A) November, 1996, and B) November, 2000.
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Comparisons between males and females.  Despite uneven age group sampling, nearly
equal numbers of males and females were screened in the two surveys.  No statistically
significant differences were seen in either survey between males and females with
regard to any measured characteristic except that of body weight.  
Figure 8.2.  Paired frequency histogram of the combined 1996 and 2000 survey
populations comparing proportions by age of severely anaemic (Hb < 6.0 g/dL) male
and female children, 6-24 months old.
Female infants in both non-critical and severely anaemic cohorts weighed significantly
less (P < 0.02) than their male counterparts.  Interestingly, males accounted for the
majority of severely anaemic children in both surveys, a difference that attained
statistical significance when the two study populations were combined (males 18.2% vs.
females 12.9%, P = 0.02).  Figure 8.2, a paired frequency histogram of this combined
population, comparing proportions by age of severely anaemic male and female
children, shows similar profiles and the suggestion of age-relatedness; lowest
proportions of severe anaemia in males and females were measured in the younger,
under 12 month age groups.  A negative correlation coefficient between age and Hb in
the combined 1996 and 2000 population attests to this relationship (r = -0.19, P < 0.01).
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Effect of irrigation and sector of residence.  Analysis of the 1996 and 2000 survey
populations was stratified according to whether children lived in irrigated or non-irrigated
communities of the KND.  Children residing in irrigated communities accounted for 57%
of the 1996 survey population but comprised only 29% of the 2000 sample (P < 0.0001).
Unexpectedly, no statistically significant differences were seen between survey years in
malaria point prevalence (66.2% vs. 62.2%), frequency of severe anaemia (19.9% vs.
10.9%, P = 0.11), mean Hb levels (7.3 g/dL vs. 7.7 g/dL), or GM parasitaemia (891/µL
vs. 1,349/µL) of children living in irrigated communities.  Significant differences were
seen in comparing between 1996 and 2000 “non-irrigated” cohorts of children; the
expected higher frequencies in 1996 of parasitaemia (72% vs. 54.5%, P = 0.0003) and
severe anaemia (25.3% vs. 13.8%, P = 0.05), and the overall mean Hb level (7.0 g/dL
vs. 7.8 g/dL, P < 0.05).  Analysis between the 1996 irrigated and non-irrigated cohorts
revealed a significantly lower mean Hb level among severely anaemic children of the
irrigated cohort (4.6 g/dL vs. 5.0 g/dL, P = 0.03) and significantly greater GM
parasitaemia among those of the non-irrigated cohort (1,549/µL vs. 891/µL, P = 0.02).
Measured characteristics of children in the November 2000 irrigated and non-irrigated
cohorts were comparable. 
Analysis by sector was performed to determine whether severe anaemia and malaria
infection in these children might be associated with residence in a particular geographic
zone within the district (North, South, East, West, and Central). Consistent differences
were seen between sectors in the prevalence of severe anaemia with highest levels in
both surveys associated with residence in the north (Fig. 8.3).  Differences between
zones in the prevalence of severe anaemia were most pronounced and statistically
significant in the 2000 survey.  Mean Hb levels of severely anaemic children did not
differ appreciably among zones but in both surveys Hb levels for the larger cohorts of
non-critical (Hb  6.0 g/dL) children followed the same zonal pattern seen with the
severely anaemic cohorts (Fig. 8.4).
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Figure 8.3.  Point prevalence of severe anaemia (Hb < 6.0 g/dL) in young children
according to geographic sector of residence within the Kassena-Nankana District,
northern Ghana: comparison of 1996 and 2000 survey results.
Figure 8.4.  Mean haemoglobin levels in young, non-critically anaemic (Hb  6.0 g/dL)
children according to geographic sector of residence within the Kassena-Nankana
District, northern Ghana: comparison of 1996 and 2000 survey results
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Blood transfusions as plausible marker of severe anaemia. Figure 8.5, which plots the
monthly numbers of young paediatric (age < 60 months) transfusions and rainfall,
shows that most transfusions went to infants under 25 months of age (381/485=78.6%) 
and there was a distinctly seasonal pattern in the frequency of occurrence.  The monthly
transfusion profile during 2000 for children < 2 years old appears to follow the very
sharply demarcated period of rains with transfusions peaking one month after the month
of greatest rainfall.  As with severe anaemia, males accounted for the majority of young
children receiving transfusions (57.5%); the frequency of transfusion for young female
children being significantly lower than that expected under conditions of equality (50%
vs. 42.5%, P = 0.01).  There was no difference between sexes in the age and Hb levels
of those receiving blood. 
Figure 8.5.  Monthly distribution of paediatric (0-5 years) transfusions during October
1999 to March 2001; separated into age  24 months (shaded bars) and 25-60 months
(open bars). 
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Pair-wise comparison by age between male and female children (Fig. 8.6) shows that
the majority of transfusion recipients in both sexes were of 5-12 months age and that
relatively few children over 36 months of age were transfused. 
Figure 8.6.  Pair-wise comparison by age between male and female children under 5
years old receiving at least 1 blood transfusion, for any reason, in the Kassena-
Nankana District Hospital during October, 1999 to March, 2001.
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8.5. Discussion
Two malaria-anaemia surveys, separated by 4 years, but conducted in the same
community and at the same November time point corresponding to early dry season in
the northern Ghana Sahel, both document alarmingly high rates and levels of anaemia
in young children 6 to 24 months old.  Independently, each survey identified
associations between severe anaemia and age, parasite rate, fever, and sex.  Relative
to children with Hb  6.0 g/dL, those with severe anaemia were older, more frequently
parasitaemic, more often febrile, and predominantly male.  Our initial hypotheses that
severe anaemia was associated with higher parasitaemias was not born out by
analysis, nor was evidence obtained to suggest that severe anaemia was associated
with younger, lower weight, female children.  
Our classification of severe anaemia, less stringent than some investigations (Snow et
al.  1998); (Tomashek et al.  2001); (McElroy et al.  2000), yet more stringent than
others (Fleming, 1987), was pragmatic, and based on Ghanaian national health policy
calling for clinical intervention in cases of Hb < 6.0 g/dL. By this classification, children
diagnosed with Hb 5.0 to 5.9 g/dL received oral ferrous sulphate while those with Hb <
5.0 g/dL were transfused.  Although more than 98% of our surveyed children fit the
clinical definition of anaemia (Hb < 11.0 g/dL) and 12.9% (75/581) of the parasitaemias
exceeded 10,000/L, only 0.6% (6/945) fit the restrictive WHO classification of severe
malaria anaemia[SMA] (Warrell et al.  1990).  This low prevalence of SMA is in contrast
with rates of 5.2% reported under conditions of fluctuating malaria in Malawi (Slutsker et
al.  1994) and rates exceeding 30% from areas of intense perennial transmission
(Lackritz et al.  1997); (Dorward et al.  1990).  Notably, however, these high rates refer
to predominantly male hospital admissions while our rate is derived from a random
cross-section of households with equal composition of boys and girls.  
The unfortunate fact of “household-level gender bias” that exists over much of the
malarious world, is assumed to account for the reduced weight, health, and survival of
infant girls, and the predominance of male hospital admissions for all causes
(Schellenberg et al.  1999); (Slutsker et al.  1994).  Hospital based studies, for this
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reason, are unsuited and unable to detect important natural differences between males
and females.  In this regard, we are impressed by random survey data indicative of a
lower risk of severe anaemia among infant girls where we had anticipated just the
opposite.  If this difference was not due simply to chance, one might speculate that the
reduced nutritional state of females renders them less capable or less suitable hosts for
parasite superinfection and density-related pathology of these infections.  Such a
protective mechanism may compensate in a small way for the greatly increased risks of
death they will later face from malaria in pregnancy (Matteelli et al.  1994).   
Sampling bias was initially considered to be the major cause underlying differences
between our studies.  There was evidence from the 1996 study that severe anaemia
continued undiminished from 18 to 24 months, and beyond, but the 2000 population
was not structured to sample these age groups and focused preferentially on children
under 12 months, where severe anaemia rates had been lower.  The 1996 population
had also been balanced in terms of children residing in irrigated and non-irrigated
communities, whereas the 2000 population sampled predominantly children from non-
irrigated compounds.  However, even after correcting for age bias, differences remained
highly significant, suggesting that rates of severe anaemia, moderate anaemia, and
parasitaemia may have improved from 1996.  Monthly rainfall profiles for the KND show
remarkable similarity over 20 years of recording, suggesting no aberrant pattern or
volume as reasons for reduced malaria and anaemia in 2000.  In fact, total rainfall in
2000 exceeded that of 1996 and closely followed the classic profile of the 20-year
average for the district. It is possible that the findings of vitamin A supplement trials
(Ghana VAST Study Team, 1993) and treated  studies (Binka et al.  1996; Binka et al.
1997; Binka et al.  1998) may have become policy and widespread practice by
November 2000.  The 1996 Ghanaian Ministry of Health Policy of free-medical care and
medicines for pregnant women and children under 5 years old also may have reduced
malaria morbidity and mortality in children of the KND by November, 2000.  
Twenty years of rainfall records show consistently that the July-August-September
quarter is the high point of the KND wet seasons each year.   Detailed studies in the
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KND have identified a corresponding pattern of child mortality in which rates increased
four-fold from April, the last month of dry season to August, the month of greatest
rainfall.  Rates of febrile illness and parasitaemia, and mean Hb levels were similarly
correlated with rainfall; infants of 6-24 months age being most affected (Binka et al.
1994).  However, the regularity of the rainfall pattern does not translate over to an
invariable pattern of malaria morbidity and death.  Young children studied over a three
year period in the KND experienced highest death rates in the first two years (1992 &
1993), during the July-September quarter, but in 1994, during the early dry season
quarter of October-December (Binka et al.  1996).  Blood transfusions performed on
young children during two consecutive years appear to follow a pattern closely dictated
by rainfall and malaria transmission.  However, despite very comparable rainfall profiles
in the two years, November stood out in 1999, as opposed to September in 2000, as the
peak month for paediatric transfusions.   We concede that other reasons may account
for a portion of the transfusions done each month, but we believe that malaria-induced
anaemia is the dominant factor underlying paediatric transfusions.  Further to this, we
speculate that longitudinal profiling of infant deaths as well as rates of severe anaemia
would closely mirror the transfusion profile each year.  
We obtained no evidence of positive or negative correlation between parasite density
and age, weight, or Hb in either individual or combined survey populations, but did
identify a relatively weak, yet statistically significant, negative correlation between age
and Hb.  Previous study of children 0-5 years old at this location had reported a
significant negative correlation between GM parasite density and Hb level (Binka et al.
1996).  This relationship was not apparent in our surveys, and may have resulted from
focusing upon younger children of 6-24 months.  Longitudinal study of Kenyan infants
from birth also determined an association between concurrent parasitaemia and lower
mean Hb, but required multiple slide readings over 90 days to show that significantly
lower mean Hb levels were related to significantly higher mean parasite densities
(McElroy et al.  2000).  
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It is well recognised that P. falciparum causes red cell destruction far in excess of that
explained by parasitaemia (Greenwood et al.  1987); (Menendez et al.  2000).  Low
level parasitaemia and chronic asymptomatic malaria, such as that seen in our study
population, is hypothesised to produce a frank suppression of bone marrow (Hviid et al.
1997); (Kurtzhals et al.  1999) and/or dysfunctional erythropoeisis (Abdalla et al.  1980);
(Weatherall et al.  1983).  African children adjust physiologically to the borderline state
of moderately severe and moderate anaemia produced and maintained by such chronic
infection but may rapidly decompensate when faced with the heightened parasitaemia
of a new infection (Newton et al.  1998) or resurgence following a partially effective
treatment (Bojang et al.  1997).
We hypothesised that residence in an irrigated area would be a risk factor for malaria
and severe anaemia owing to increased density of infective mosquitoes and perennial
transmission, but no clear pattern of increased risk was apparent in our analysis.  This
result is suggestive of a uniform condition of malaria transmission over the entire KND,
virtually equalising irrigated and non-irrigated communities for a time, hence our failure
to detect any November differences between irrigated and non-irrigated cohorts.
Alternatively, malaria transmission affecting young children in irrigated sectors may be
so much more intense and regular as to induce an earlier, broader, and stronger
immunity than that triggered only periodically by seasonal malaria in the non-irrigated
sectors.  Such an edge, or disproportionate immunity in the irrigated cohort might
originate from immediately protective higher titre maternal antibodies transferred during
gestation and breast feeding, foetal haemoglobin, and subsequently, by self-made
cellular and humoral responses to a continuum of infections (McGregor, 1965); (Pasvol
et al.  1977); (Snow et al.  1998).  Although we failed to detect clear differences
between irrigated and non-irrigated cohorts in either survey, we observed that anaemia
was more pronounced among children of the northern sector.  As this was seen in both
surveys and manifested in multiple factors (proportions of severely anaemic children,
mean Hb levels among non-critical children), we consider these differences to be valid
and suggestive of increased risk.  Greater risk of severe anaemia in the north may
derive from 1) distance from medical treatment facility, 2) less effective or delayed
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protective immunity, and 3) nutritional and economic stress.  Based upon these initial
observations we hypothesise that differences between locations would be even more
apparent during the truly dry months of December to April.  
In summary, severe anaemia in the northern Ghana Sahel appears to be a regular and
near-predictable seasonal event that is akin to a grim  “rite of passage” for young
children of rural Africa.  Under starkly seasonal conditions that rigidly delimit malaria
transmission, we identified high rates of severe anaemia among males and older
children in the infant age group studied, and obtained evidence associating anaemia
severity with residence in the northern sector of the KND.  We believe that the daily
record of blood transfusions performed at the district hospital is a simple, valuable index
that is reflective of the intensity of malaria, malaria-induced anaemia, and malaria death
in this district.   From recent demonstrations of success against the high level of severe
malaria anaemia that occurs under conditions of continuous heavy transmission
(Menendez et al.  1997); (Schellenberg et al.  2001); (Tomashek et al.  2001), we are
inclined to advocate a similar attack against infant anaemia as it occurs in the KND.
This strategy, based on provision of oral iron syrup to mothers and simple presumptive
intermittent treatment of young children with Sulphadoxine-Pyrimethamine (SP), both
timed in accordance with childhood immunisations and given through the existing
infrastructure of the WHO Expanded Program of Immunisation (EPI) could improve
health and save many young lives. 
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Chapter 9: General Discussion, Conclusions and Recommendations
The main goal of the work presented here is to contribute to the understanding of the
epidemiology of Plasmodium falciparum parasites, the patterns of seasonality in
infection and morbidity and their relationship to radical cure in the Kassena-Nankana
district (KND) of northern Ghana.  The findings from these studies are discussed in
detail in each of the chapters. The general discussion of the design, methodology and
the contribution of the results from these studies to our knowledge of Plasmodium
falciparum infections and future control of the disease through clinical interventions
have been addressed in this chapter.
9.1. Study population, Design and Methodology of the studies
All the studies presented here were carried out in the Kassena-Nankana district (KND)
in northern Ghana. The district has been described in detail in section 2.3.
Selection of participants: Cluster randomisation was used in sampling participants in all
these studies. Though cluster randomisation is considered to be less efficient and has
weaker statistical power relative to a design individually randomising the same number
of subjects, we had to adopt it mainly because of logistical and cost constraints. This did
not compromise the quality of the study and the inferences drawn because, we tallied
the total number of eligible members of the community within the 4 geographic zones of
the district and randomly selected 16 "index" compounds. Using the Stata programme
the selection was stratified by zone, based on population parameters, estimated as
weighted averages of the age-specific values, weighed in proportion to the total district
population in the age group. The SAS GENMOD (SAS Institute Inc., 1996) procedure
was used to compute confidence intervals, allowing for the clustering. 
The selection was facilitated by the availability of the Navrongo Demographic
Surveillance System (NDSS), a longitudinal census of all district residents that is
updated every 3 months. With the target population already on the NDSS database, the
eligible individuals of the target group of each of the "index" compounds followed by
nearby compounds were recruited into the study, sufficient to allow for cluster sampling
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analysis. We involved all age groups (1 week to 85 years) in the cohort used for the
molecular epidemiological studies, ensuring that each age group was adequately
represented in the cohort. In the incidence studies, we studied a cohort of semi-immune
inhabitants (18-55 years) at the end of the peak transmission season (May-October) of
1996. This was followed by the recruitment of a cohort of non-immune infants/young
children (6-24 months of age) in November 1996, a time coinciding with low malaria
transmission. We followed this with the recruitment of a second cohort of infants/ young
children of the same age group in May 1997, exactly one year after the adult cohort to
coincide with the high transmission season of 1997. In studying the two infant/child
cohorts, haemoglobin levels were determined using automated haemocue (details in the
chapters). The striking difference in severe anaemia levels in November 1996 (a period
following the high transmission season of 1996) and May 1997 (a period following the
low transmission season) led to a repeat survey in November 2000. This was to
establish whether the peak in anaemia levels in 1996 is a regular annual event. 
Laboratory procedures:
Microscopy: All blood slides were stained using the standard Giemsa method and the
procedure for reading and assessing parasite densities was the same. The details are
found in the various chapters. Parasite counts were converted to parasites per microlitre
of blood assuming an average of 8000 leukocytes per µl blood. This standard procedure
has been used all these years in malariometric surveys carried out in this region as it is
internationally accepted. It will be a useful exercise, however, to check the number of
leukocytes per microlitre of blood in one of the future surveys to re-assure malariologists
of the validity of this standard conversion. Most of the slides from these studies were
read by a microscopist with considerable experience in this field of specialisation. Re-
reading of a blinded 10% random selected microscopic slides showed very high
agreement between the two readers. We had the opportunity to compare the latest
microscopy readings with PCR results carried out in the most recent survey (refer
chapter 3). 
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Considering the fact that the two methods were applied independently and blind, there
was a very high level of agreement between microscopy and PCR for positivity for
Plasmodium falciparum (Figure 3.2). This validates the parasitological data reported in
the past in studies carried out in the KND. As in other studies (Muller et al.  2001), the
positive samples that were missed by microscopy were predominantly in older
individuals who generally have low parasite densities and significantly lower mean
multiplicity of infection than the average in the community.
PCR: Deoxyribonucleic acid (DNA) on DNA-Isocode stix was added directly to the PCR
mix. Both primary and nested PCR were performed with each sample to optimise
sensitivity. The msp2 gene of P. falciparum was genotyped by the Polymerase Chain
Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) approach of (Felger
et al.  1999). This method was preferred to the other major method used for msp2
genotyping i.e. analysis of size polymorphism with subsequent hybridisation with family-
specific probes (Foley et al.  1992);  (Carter et al.  1973); (Ntoumi et al.  1995). In order
to study the infection dynamics of individual genotypes and to be able to follow a single
parasite clone over time, the use of an extremely polymorphic marker is an essential
pre-condition. Despite the views of (Babiker et al.  1999) that the use of one marker, no
matter how polymorphic, would miss variation at other polymorphic loci and thus almost
certainly underestimate the magnitude of multiple infections, only the msp2 marker was
analysed in this study. A comparison of multiplicity obtained from one locus (by PCR-
RFLP) versus two loci genotyping indicated that additional information was gained only
in 2.6% of infections, all being infections with a single parasite clone (Felger et al.
1999).  To use two less polymorphic marker genes instead cannot fulfil this task
because the marker genes are not genetically linked. For genotyping blood samples
from Ghana, with a mean-multiplicity of 3.4 (range 1-8) genotypes per PCR-positive
sample, it was therefore concluded that the PCR-RFLP technique using a single locus
only, was the method of choice to address the questions that are of interest to us. Msp2
genotyping makes it possible to determine the multiplicity of infection, which can be
used as an outcome measurement of interventions such as drug/vaccine trials, or
exposure-reducing interventions. Restriction digests of the PCR products were
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performed with Hinf I for 2 hours and then run on a 10% PAA gel. When a higher
discriminatory power of the RFLP pattern was desired, usually in the case of new alleles
or ambiguities, an additional Dde1 digest was performed. We identified individual clones
by allele-specific patterns; up to 8 different clones were distinguished (Felger et al.
1999).
9.2. General Discussion of the findings from these studies
This section is divided into four main parts, the first part discusses incidence of infection
and disease among non-immune children (6-24 months) and in semi-immune adults
(18-55 years) and application of the results for optimal design of clinical intervention
trials, including testing of malaria vaccines. This is followed by a discussion of the
molecular epidemiology of P. falciparum infections in the locality and how such
knowledge could be used in the assessment clinical malaria intervention trials. A
discussion of the effects of clearing malaria parasites on incidence and severity of
morbidity at re-infection is covered in the third section. The fourth section discusses
malaria morbidity trends in the Kassena-Nankana district (KND), focusing on the
seasonal characteristics of severe anaemia. This has been discussed in the context of
using severe malaria anaemia as possible end points in the evaluation of malaria
clinical studies, including malaria vaccine studies.
Incidence data and applicability to optimal design of malaria intervention studies: The
results from these studies show that malaria transmission in the Kassena-Nankana
district (KND) is intense throughout the year but with seasonal peaks and troughs. The
incidence density (ID) of infection which estimates the force of Plasmodium falciparum
infection in infants and young children who were non-immune was the same as in semi-
immune adults during the wet season (ID = 7 cases/person-year). This only decreased
slightly among the non-immunes during the dry season when malaria transmission is
usually low in KND (ID = 5.0 cases/person-year). Despite a natural immunity derived
from a lifetime of intense exposure, these adults studied became rapidly re-infected
following an effective curative treatment. Neither genetic resistance nor long-acquired
immunity appears to be sufficiently strong or widely present in this population to
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completely inhibit parasitaemia. This observation suggests that antisporozoite antibody
is poorly developed under natural conditions and appears not to protect against
development of malaria infection, in support of the finding of (Carter et al.  1973).
(Hoffman et al.  1987) in their study in western Kenya wondered whether any level of
naturally acquired antibodies to the circumsporozoite protein can predict resistance to
Plasmodium falciparum malaria. The data from KND supports the views of (Hoffman et
al.  1987), that prevention of malaria infection is unlikely, no matter the immune status of
an individual; unless these individuals are immunised with sporozoite vaccines that
induce antibodies superior to the CSP antibodies existing in these individuals. This
general susceptibility and rapid appearance of low density blood stage infections may
result from the ineffectiveness of anti-sporozoite and anti-liver stage immunity or to an
asexual blood stage effect coupled with a pre-erythrocytic stage immunity that reduces
but does not completely eliminate all infected hepatocytes (Hoffman, 1996).
The cumulative incidence profiles of adult and infant cohorts in the wet season in the
KND indicate the same rapid rise and plateau effect with over 90% re-infection rate
within twelve weeks post-treatment (Fig. 6.4). These incidence data are available for
use in estimating appropriate sample sizes for intervention trials, drugs and vaccines
inclusive. For example, using the results from these studies as a hypothetical case for
non-immune children, the statistical power of a vaccine trial applying endpoints of high
parasitaemia (>50,000/ul) and fever can best be illustrated.  If one assumes a vaccine
efficacy of 85%, and the operational requirement to have an 80% probability of having a
95% confidence interval that excludes 70% (i.e., the lower limit of acceptability for
efficacy), then the dry season incidence rate of 0.24 events per person year for this
outcome demands a sample size of 2055.  Applying the same parameters to the 1.04
events per person year incidence rate in the wet season for the same non-immunes
gives a sample size estimate of just 363 subjects. In the case of the semi-immune
adults, applying the finding of an 80% attack rate to a prospective12 week trial of a
drug/vaccine with predicted 75% protective efficacy (PE), and an 80% probability
(power) of having the lower 95% confidence limit for that PE >70%, we would require a
population of 1,004 adults.  With these variables kept the same, but with the lower 95%
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confidence limit relaxed to >60% for the PE, we would need only to enrol 151 subjects.
These clearly demonstrate that subtle distinctions in seasonal end point incidence
densities could profoundly impact sample size requirements in intervention trials.
The results from these incidence studies were applied in the design of a randomised,
double blind, placebo-controlled dose-ranging chemoprophylaxis drug trial in 1998 in
the KND. A cluster random sample of roughly 500 semi-immune adults in this
community were studied to determine the minimum effective weekly dose of
Tafenoquine (TQ) for prevention of infection by Plasmodium falciparum (Table 9.1). 
Table 9.1.  Primary outcomes: Incidence and protective efficacy (PE) relative to placebo
Placebo TQ
25 mg
TQ
50 mg
TQ
100 mg
TQ
200 mg
MF
250 mg
No. Subjects 94 93 91 94 91 46
No. positive malaria smears 86 58 13 11 12 6
Total person-weeks* 505 801 1059 1132 1087 555
Cumulative Incidence/12 wks 0.93 0.65 0.16 0.13 0.14 0.13 
Incidence Density/person-yr 8.9 3.8 0.6 0.5 0.6 0.6
%Protective Efficacy** N/A 56.9 92.8 94.3 93.5 93.7
Lower 95% CI N/A 39.9 87.1 89.3 88.1 88.1
Upper 95% CI N/A 69.1 96.0 96.9 96.5 97.2
CI = Cumulative incidence; wks = weeks; yr = years;   *Follow-up time until positive blood smear, negative early drop-out, or
negative at the 12 week endpoint. **% Protective efficacy = [1-(drug incidence density/placebo incidence density)] x 100
MF = Mefloquine, TQ = Tafenoquine, mg = milligrams.
The study was designed to end by 12 weeks of follow-up and a sample size based on
the cumulative incidence (CI) results from the incidence studies. By the end of the 12-
week follow-up period, all the four Tafenoquine doses in this blinded study
demonstrated highly significant protection from malaria infection relative to the placebo
and Mefloquine groups. The conclusion from this study was that Tafenoquine doses of
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50, 100, and 200 mg/wk were safe, well tolerated, and as effective as Mefloquine at 250
mg/wk in this rural African population (Hale et al., 2000). 
Molecular epidemiology of Plasmodium falciparum infections and relevance to
assessment of clinical malaria interventions: Molecular analysis of parasites collected in
this survey in the Kassena-Nankana district (KND) demonstrates that parasite
multiplicity is very large in this community, with most asymptomatics carrying multiple P.
falciparum genotype infections. The multiplicity of infection seen in the KND was
comparable with other holoendemic malarious areas (Hill et al.  1995); (Smith et al.
1999c); (Engelbrecht et al.  2000); (Ntoumi et al.  1995). The two msp2 allelic families
were of almost equal proportions in KND [FC27 (49%) and 3D7 (51%)], supporting the
suggestion by (Felger et al.  1999), that though the genetic diversity at this locus is
extensive, it is limited by structural constraints or immune selection. 
The age pattern in multiplicity and parasite density among children in the KND revealed
results similar to observations made in other holoendemic sites (Ntoumi et al.  1995);
(Smith et al.  1999b). The peaks of multiplicity of infection and parasite densities were in
different age groups, which gives an indication that the mechanisms for multiplicity of
infection and parasite densities are not the same. Further evidence for this is provided
by the age profile of the correlation between parasite density and multiplicity in
Kilombero where a gradual loss of the correlation between parasite density and
multiplicity with age was observed (Smith et al.  1999b). This age profile matched that of
the acquisition of clinical immunity. This could reflect specific anti-parasite immunity
acquired after about 10-15 years of age in holoendemic areas. Antigenic polymorphism
in malaria appears to be one of the important mechanisms deployed by the parasite to
evade immune responses (Mendis et al.  1991). Knowledge of how to counteract this
immune evasion will provide guidance to antigens that will stimulate highest quantity of
effective antibodies and the best conditions under which immunisation can be
conducted in malaria vaccine trials. 
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The steady and gradual increase in the correlation between multiplicity and parasite
density after the age of 10 observed until over 60 years of age in KND was however,
unexpected. Given the very low densities observed in older participants and the
diversity of the parasites, it could be that multiplicity might simply be counting the
number of individual parasites in the sample. The existence of a correlation between
multiplicity and density could then be an indication of accurate quantitation of low-
density parasitaemia.
Parasites carrying the FC27-like genotypes have been found to be more frequently
associated with symptomatic malaria patients compared with asymptomatic ones
(Engelbrecht et al.  1995); (Al Yaman et al.  1997). The association between the allelic
family type and the frequency of malaria disease could not be discussed as only 3.6%
of the participants had documented fever (axillary temperature  37.5oC) and 2.3% of
participants had fever associated with malaria parasitaemia. The findings from this
study presented in chapter 3, constitutes the baseline of a longitudinal study designed
to collect parasitological data at eight weeks intervals from individuals of all age groups
over a period of one year. It is envisaged that the links between allelic families and
symptomatology can be determined when the data from the repeated surveys are pulled
together and the allelic family types of the symptomatic ones are re-analysed in
comparison with the asymptomatic ones. Mention could be made of an intervention trial
that is ongoing in the KND, in the same communities where these genotyping studies
were carried out, to evaluate the effects of treatment with Artesunate suppositories on
child mortality (Gyapong et al., 2000). Severely ill (nil per Os) malaria patients are the
target for this study. In order to address questions related to the multiplicity of infection
and it relationship to severe-complicated clinical malaria, blood samples are currently
being collected on filter paper samples (Owusu-Agyei, protocol 2001) from all the
severely ill children identified within the context of this trial for genotyping later on. The
relationship between allele types and severity of malaria will be established from this
add on study.
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At the beginning of the wet season, the data from the KND demonstrates one of the
highest multiplicity with age dependence patterns similar to those in other holoendemic
sites in Africa, thus validating the use of the age-multiplicity relationship as an indicator
of malaria endemicity. However, the age-patterns of multiplicity could differ significantly
in the dry season especially in the non-irrigated areas of the district. Data from the
additional surveys will allow us to build upon these baseline results and contribute to our
knowledge and understanding of the seasonal dynamics and multiplicity of infections in
all age groups in this area of highly seasonal holoendemic malaria. The availability of
genotyping data will contribute to evaluating intervention programmes by way of
studying the changes in multiplicity with time (ie reduction of parasite clones following
an effective intervention), the role and dynamics of disease causing alleles, ie how
alleles appear and disappear, which ones appear or not at the time of clinical malaria
and the effects of dominant genes in clinical malaria attacks. 
Clearance of parasitaemia and effects of subsequent infections in intervention trials: It
remains unclear whether it is a good idea to clear malaria parasitemia prior to an
intervention so that the effect of the intervention can be evaluated. Over 30 years ago,
(Pringle & Avery-Jones, 1966) concluded from studies carried out in western Kenya that
even short period of a few weeks of drug protection against malarial infection lowered
the immunity of the children studied appreciably. This resulted in clinical symptoms of
malaria and a parasitaemia that was significantly greater than had prevailed generally
before treatment. Up to date, the question about the effects of completely clearing
malaria parasites prior to assessing malaria interventions still remain relevant,
especially to intervention trials where subtle differences in susceptibility affect end
points of effective or ineffective outcomes. A direct evaluation of the possible impact on
incidence and severity of subsequent symptomatic malaria is required. 
In chapter 4, 20% of the adult volunteers, who received treatment prior to being
followed-up for incidence of malaria infection, developed clinical malaria attacks at first
re-infection (Owusu-Agyei, 2001). Furthermore, close to half of these volunteers had
experienced a clinical malaria attack by the end of the 20 weeks follow-up period. 
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These disease rates in adults raise the question of whether clearance of malaria
parasitaemia could have increased the risk of clinical attacks when they subsequently
became re-infected. 
The tendency for the incidence of clinical malaria to be lower among untreated
volunteers who had parasitaemia at enrolment than among those who had no
parasitaemia at enrolment as reported in our studies, further suggests that the retention
of parasites among semi-immune adults may be protective. Similarly, the fact that the
treated cohort became sick after less time at risk than the controls is remarkable since
parasites were present in the controls from the start of follow-up.  Furthermore, within
the control cohort, those who were microscopically positive at enrolment took longer
time to develop clinical malaria as compared with those who were microscopically
negative at enrolment.  For these reasons it could even be the case that the effect of
radical therapy on disease incidence is substantially greater than we estimated.
The doubling of parasite densities in both adults and children at first clinical malaria
following radical therapy compared to their enrolment parasite densities (p<0.001 for
each cohort) can be attributed to the effect of radical cure. Pringle & Avery-Jones (1966)
reported similar results, a significantly higher malaria parasitaemia was observed
among semi-immune children following parasite clearance.  Although it is difficult to rule
out drug-mediated interference with immune effectors that limit parasite densities as an
explanation, diminished effectiveness of premunition (ie the presence of established
infections in an individual offering cross-protection against invading clones either by
preventing superinfecting clones from becoming established or via tolerance of the new
infections), as a consequence of eradication of parasitaemia by radical curative therapy
is favoured. The elimination of chronic, relatively low-grade parasitaemia may have
established susceptibility to acute, relatively high-grade parasitaemia. This is supported
by the 100% response to Chloroquine treatment among the radical therapy cohort
compared to the 9% parasitological failure rate among the untreated cohort. Untreated
individuals in holoendemic areas often harbour many clones of parasites (Ntoumi et al.
1995); (Beck et al.  1997; Rougemont et al.  1991) and so the chances of a Chloroquine
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resistant strain being present is higher than the resistance rate for single infections. This
carries important implications with regard to experimental design in intervention studies
and to control strategies aimed at delivering effective therapies in holoendemic Africa.
There has also been long-standing discussion on rebound effects following successful
interventions such as s (Snow et al.  1997) and the use of chemoprophylaxis or drug
treatments (Menendez et al.  1997); (van den et al.  1996); (Greenwood et al.  1995).
The evidence so far suggests that clinical malaria occurring after clearing of parasites
may be distinctly different from the “natural” disease. As radical cure is a part of the
standard strategy for evaluating malaria vaccines (World Health Organisation, 1997a)
these findings may have significance for the design and interpretation of such trials.
Though the work that we carried out came up with findings supporting earlier work
related to clearance of parasitaemia, the treatment and control cohorts in our study
were not randomised and followed within the same time. Drawing concrete conclusions
become quite difficult. There is therefore the need to carry out a double blind,
randomised placebo-controlled treatment trial. 
Trends of severe anaemia in KND & the relevance in assessment of intervention trials:
Anaemia is an important feature of morbidity caused by malaria in the Kassena-
Nankana District (KND). Two malaria-anaemia surveys, separated by 4 years, but
conducted in the same community and at the same November time point corresponding
to early dry season in northern Ghana, both document alarmingly high rates and levels
of anaemia in infants and young children 6 to 24 months old.  Independently, each
survey identified associations between severe anaemia and age, parasite rate, fever,
and sex.  Relative to children with Hb  6.0 g/dL, those with severe anaemia were
predominantly male, older, more frequently parasitaemic, and more often febrile. These
randomly selected cohorts of infants and young children showed dramatic distinctions
with respect to the prevalence of severe anaemia as seen at enrolment at the end of the
wet and dry seasons (Koram et al.  2000).  In effect, an epidemic of severe malarial
anaemia occurred in these children as the wet season progressed: apparently starting
at 1% in May and rising to 22% by October. The relatively brief respite in transmission
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between February and May appeared sufficient to allow recovery of most severe
anaemia to above the 6.0g/dl level. 
The contribution of nutrition and worm load to the anaemia status of these young
children was investigated to see if they play any significant role. Though the nutritional
status of these infants/young children demonstrated that there was general wasting and
stunting in their growth as measured by anthropometric indices (Koram et al.  2000);
(Owusu-Agyei et al., 2001a), there was no seasonal variation in nutritional status in
these young children. The time of the wet season surveys (November 1996 and
November 2000) is a period that coincides with high food stores and if anything this
should have impacted positively on the nutritional status of these young children. We
see the children worse off at this time in terms of their anaemia levels, clearly indicating
that nutrition is generally a problem in the KND, but was not the cause of the sharp
seasonal difference in haemoglobin levels observed.  In diarrhoea studies carried out in
the KND from 1998 to 2000, involving infants/young children of the same age group (6-
24 months old), only one child out of over 1500 children examined by microscopy of
faeces was reported to have been infected with hookworm (Anto, personal
communication). Other helminth eggs were absent in the stools of these infants/young
children.
Infection with P. falciparum is known to be one of the major causes of childhood
anaemia in malaria endemic areas (Orago et al.  2001); (Menendez et al.  2000);
(McElroy et al.  2000).  A strong correlation has been reported between the incidence of
severe anaemia, the age-specific rates of anaemia and the intensity of P. falciparum
transmission. Malaria control trials have usually been followed by marked improvements
in haematological indices in children (Alonso et al.  1991); (Greenwood et al.  1987);
(Molyneux et al.  1980). With such intense malaria transmission in the KND, and the
seasonal peaks and troughs in anaemia levels, there is no doubt that P. falciparum
infections are responsible for the severe anaemia in the age group that we studied in
this district. Children suffer from repeated attacks of malaria during the wet season.
The frequent attacks do not give these children enough time for complete recovery from
136
one infection, as a result, a marked drop in haemoglobin levels result by the end of the
high transmission season.
Anaemia in children is a commonly reported problem from hospitals and clinics in
malaria endemic countries.  In the KND, it accounted for 22% of all hospital admissions
in the year 2000 (Owusu-Agyei et al., 2001b). Blood transfusions performed on young
children during two consecutive years appear to follow a pattern closely dictated by
rainfall and malaria transmission, and peaked around the November month. We
speculate that longitudinal profiling of infant deaths as well as rates of severe anaemia
would closely mirror the transfusion profile each year. This assessment will be made
using the Navrongo Demographic Surveillance System (NDSS) mortality data collected
over the years for such analyses. 
Severe anaemia in the northern Ghana appears to be a regular and near-predictable
seasonal event among the infants and young children. This relatively high prevalence of
anaemia observed as a regular annual event that follows the high transmission season
each year, opens up the possibility of using incidence of anaemia as a primary outcome
variable for the effects of novel intervention tools such as vaccines, at least in areas of
high malaria transmission such as the Kassena-Nankana district in northern Ghana. 
The recent demonstration of Sulphadoxine-Pyrimethamine (SP) success against the
high level of severe malaria anaemia that occurs under conditions of continuous heavy
transmission (Menendez et al.  1997); (Schellenberg et al.  2001); (Tomashek et al.
2001), can be used in making a case for evaluating malaria vaccines using anaemia as
an end point.  This strategy, based on provision of oral iron syrup to mothers and
intermittent treatment of infants and young children with SP, both timed in accordance
with childhood immunisations and given through the existing infrastructure of the WHO
Expanded Program of Immunisation (EPI) could improve health and save many young
lives. 
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9.3. Conclusions and Recommendations 
In conclusion,
Malaria transmission was found to be intense throughout the year, with seasonal peaks
and troughs. The overall P. falciparum microscopy prevalence was 70%, with the
highest parasite rates among 5-9 year olds and highest parasite density (geometric
mean 1,922/µl blood) in 1-2 year olds.. 
The incidence studies have documented intense malaria transmission with incidence
densities between 5 and 7 infections/person-year occur through most of the year among
non-immune infants/young children aged 6 to 24 months and semi-immune adults (18-
55 years of age) living in the Kassena-Nankana District of northern Ghana. Within the
20-week wet season virtually all and infants/young children and adults had manifested a
patent primary infection and many reported illnesses that coincided with parasitaemia.
Adults experienced predominantly low-density infections, characterised by mild clinical
illness while infants/young children have high-density infections with more severe forms
of clinical illness. The findings can be used for optimal design of malaria clinical
interventions. 
Evaluation of some malaria clinical intervention trials will require clearance of
parasitaemia prior to follow-up. The interpretation of such intervention trials need to be
carried out with a lot of caution as clinical malaria occurring after radical therapy may be
distinctly different from the “natural” disease, and the implications of treating
asymptomatic individuals may be very different in adults than for children. Results from
these studies also support the view that clearance of parasitaemia may put individuals
at increased risk of subsequent clinical malaria in terms of duration and severity.
The genotyping study also demonstrated 82% P. falciparum prevalence by PCR with a
high multiplicity of infection in this community. PCR-RFLP typing of the P. falciparum
msp2 gene revealed a mean msp2 multiplicity of 3.4 (range: 1 to 8) genotypes with the
two msp2 allelic families (FC27 and 3D7) in almost equal proportions. The correlation
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between parasite density and msp2 multiplicity was highest in infants, and decreased
with age to a minimum by 10 year, then start to increase again from this age to
adulthood. The patterns of age dependence are similar to those in other holoendemic
sites in Africa, validating the use of the age-multiplicity relationship as an indicator of
malaria endemicity. Results from repeat surveys designed for seasonality will soon be
available to build up an all-year round molecular epidemiology of P. falciparum
infections in the KND. The availability of these data will contribute significantly in
evaluating intervention programmes. The changes in multiplicity with time (ie reduction
of parasite clones following an effective intervention), the role and dynamics of disease
causing alleles, and the effects of dominant genes in clinical malaria attacks. 
The evidence suggests that dramatic peaks and troughs of severe anaemia are regular
and possibly predictable events that may be used to gauge the health and survival of
young children in this area. The high prevalence of anaemia observed at the end of the
high transmission season opens up the possibility of using severe anaemia as a primary
outcome variable for the effects of novel intervention tools such as vaccines, at least in
areas of high malaria transmission. 
These studies provide the foundation for designing efficient, practical clinical
intervention trials and preventive strategies against malaria in this holoendemic region.
The studies can also be evaluated with end points that have been documented from our
findings.
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Recommendation: 
The question about the effects of completely clearing malaria parasites prior to
assessing malaria interventions still remain relevant, especially to intervention trials
where subtle differences in susceptibility affect end points of effective or ineffective
outcomes. As the study of the initial cohort was not designed to investigate the effects
of radical therapy, the untreated group was studied a year after the treated cohort.
Studies designed to address this important question about the effects of radical cure on
incidence and severity of clinical malaria needs to be investigated in a more scientific
manner in which the treatment and placebo groups are randomised and followed up
concurrently.
In studying the effects of radical therapy on incidence and severity of morbidity, the
opportunity should be taken to collect blood samples for DNA studies such as
determining whether treatment affects rates of acquisition and the duration of individual
P. falciparum infections by genotyping msp1 and msp2 gene markers. Other research
areas include, comparing the rates of acquisition and the duration of individual P.
falciparum clones in non-immune children with those in semi-immunes. Examining
whether morbidity is invariably associated with the acquisition of new parasite clones, or
related to prior low multiplicity and whether multiplicity is a function of long-term immune
status of an individual. 
It is recommended that questions related to the multiplicity of infection and its
relationship to severe/complicated clinical malaria are addressed. Blood samples are
currently being collected on filter paper samples (Owusu-Agyei, protocol, 2001) from all
the severely ill children identified within the context of the Artesunate suppository trial
currently ongoing in the KND for genotyping later on. It is expected that the relationship
between allele types of msp1 and msp2 and severity of Plasmodium falciparum malaria
will be established from this add on study. We will test whether a particular allelic family
will be dominantly found in severe cases using quantitative allele family specific PCR.
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The findings reported in chapters 7 and 8 calls for longitudinal studies of seasonal risk
of severe anaemia in northern Ghana. The relatively brief respite in transmission
between February and May each year appears to be sufficient to allow recovery of most
severe anaemia to above the 6.0g/dl level. The process of recovery from their low
haemoglobins following the wet season needs to be investigated.
We speculate that longitudinal profiling of infant deaths as well as rates of severe
anaemia would closely mirror hospital transfusion profile each year. This assessment
will be made using the Navrongo Demographic Surveillance System (NDSS) mortality
data collected over the years for such analyses. 
Severe anaemia in the KND appears to be a regular and near-predictable seasonal
event among the infants/young children, and follows the high malaria transmission
season each year. It therefore opens up the possibility of using incidence of anaemia as
a primary outcome variable for the effects of malaria vaccine trials. This needs to be
explored for future malaria intervention studies. 
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